Diseases
Gastrointestinal Neoplasms
Gastrointestinal Neoplasms
Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.

A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. (1/1704)

The use of megestrol acetate in the treatment of weight loss in gastrointestinal cancer patients has been disappointing. The aim of the present study was to compare the combination of megestrol acetate and placebo with megestrol acetate and ibuprofen in the treatment of weight loss in such patients. At baseline, 4-6 weeks and 12 weeks, patients underwent measurements of anthropometry, concentrations of albumin and C-reactive protein and assessment of appetite, performance status and quality of life using EuroQol-EQ-5D and EORTC QLQ-C30. Thirty-eight and 35 patients (median weight loss 18%) were randomized to megestrol acetate/placebo or megestrol acetate/ibuprofen, respectively, for 12 weeks. Forty-six (63%) of patients failed to complete the 12-week assessment. Of those evaluable at 12 weeks, there was a decrease in weight (median 2.8 kg) in the megestrol acetate/placebo group compared with an increase (median 2.3 kg) in the megestrol acetate/ibuprofen group (P<0.001). There was also an improvement in the EuroQol-EQ-5D quality of life scores of the latter group (P<0.05). The combination of megestrol acetate/ibuprofen appeared to reverse weight loss and appeared to improve quality of life in patients with advanced gastrointestinal cancer. Further trials of this novel regimen in weight-losing patients with hormone-insensitive cancers are warranted.  (+info)

Predicting delayed anxiety and depression in patients with gastrointestinal cancer. (2/1704)

The aim of this study was to examine the possibility of predicting anxiety and depression 6 months after a cancer diagnosis on the basis of measures of anxiety, depression, coping and subjective distress associated with the diagnosis and to explore the possibility of identifying individual patients with high levels of delayed anxiety and depression associated with the diagnosis. A consecutive series of 159 patients with gastrointestinal cancer were interviewed in connection with the diagnosis, 3 months (non-cured patients only) and 6 months later. The interviews utilized structured questionnaires assessing anxiety and depression [Hospital Anxiety and Depression (HAD) scale], coping [Mental Adjustment to Cancer (MAC) scale] and subjective distress [Impact of Event (IES) scale]. Patient anxiety and depression close to the diagnosis were found to explain approximately 35% of the variance in anxiety and depression that was found 6 months later. The addition of coping and subjective distress measures did little to improve that prediction. A model using (standardized) cut-off scores of moderate to high anxiety, depression (HAD) and intrusive thoughts (IES subscale) close to the diagnosis to identify patients at risk for delayed anxiety and depression achieved a sensitivity of 75% and a specificity of 98%. Levels of anxiety and depression at diagnosis predicted a similar status 6 months later. The results also indicated that the HAD scale in combination with the IES intrusion subscale may be used as a tool for detecting patients at risk of delayed anxiety and depression.  (+info)

Management and outcome of patients undergoing surgery after acute upper gastrointestinal haemorrhage. Steering Group for the National Audit of Acute Upper Gastrointestinal Haemorrhage. (3/1704)

Most patients with acute upper gastrointestinal haemorrhage are managed conservatively or with endoscopic intervention but some ultimately require surgery to arrest the haemorrhage. We have conducted a population-based multicentre prospective observational study of management and outcomes. This paper concerns the subgroup of 307 patients who had an operation because of continued or recurrent haemorrhage or high risk of further bleeding. The principal diagnostic group was those with peptic ulcer. Of 2071 patients with peptic ulcer presenting with acute haemorrhage, 251 (12%) had an operative intervention with a mortality of 24%. In the non-operative group mortality was 10%. The operative intervention rate increased with risk score, ranging from 0% in the lowest risk categories to 38% in the highest. Much of the discrepancy between operative and non-operative mortality was explainable by case mix; however, for high-risk cases mortality was significantly higher in the operated group. In 78% of patients who underwent an operation for bleeding peptic ulcer there had been no previous attempt at endoscopic haemostasis. For patients admitted to surgical units, the operative intervention rate was about four times higher than for those admitted under medical teams. In patients with acute upper gastrointestinal haemorrhage operative intervention is infrequent and largely confined to the highest-risk patients. The continuing high mortality in surgically treated patients is therefore to be expected. The reasons for the low use of endoscopic treatment before surgery are not revealed by this study, but wider use of such treatments might further reduce the operative intervention rate. Physicians and surgeons have not yet reached consensus on who needs surgery and when.  (+info)

Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. (4/1704)

The c-kit gene encodes a transmembrane receptor kinase (KIT) which is expressed in the majority of human gastrointestinal stromal tumors (GISTs), a subtype of gastrointestinal mesenchymal neoplasms. A previous study identified mutations in the juxtamembrane (JM) domain of c-kit in five of six GISTs (Science 279: 577, 1998). To better define the frequency and spectrum of c-kit gene mutations in mesenchymal neoplasms of the GI tract that had been characterized for KIT protein expression, we examined archived tissue samples for mutations in the JM domain by PCR amplification and DNA sequencing. c-kit JM domain mutations were found in nine of 56 mesenchymal tumors (46 GISTs, eight leiomyomas, two leiomyosarcomas) and occurred exclusively in GISTs (21%). Seven of the nine mutations consisted of intragenic deletions of one to 19 codons. There was one insertion mutation that added 12 codons and one missense mutation (Val560Asp). None of the mutations disrupted the downstream reading frame of the gene. The single missense mutation (Val560Asp) is very similar to the only other missense mutation reported in GISTs (Val599Asp). Of the 46 GISTs, 43 were strongly positive for KIT protein expression and negative for diffuse expression of desmin. Neither KIT expression nor gene mutations were found in gastrointestinal leiomyomas or leiomyosarcomas. We conclude that mutation of the c-kit JM domain does not occur in gastrointestinal mesenchymal neoplasms with well developed-smooth muscle differentiation, and is restricted to GISTs. However, since these mutations are only found in a minority of GISTs, further investigation into the mechanisms of c-kit gene activation in this group of neoplasms is warranted.  (+info)

Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. (5/1704)

An3 1 KAL I MutL homologue 1 (MLH1) is a member of the family of proteins required for DNA mismatch repair. Germ-line mutations in MLH1 lead to the cancer susceptibility syndrome hereditary nonpolyposis colorectal cancer (HNPCC). We generated mice carrying a null mutation in the Mlh1 gene. We showed that mice heterozygous and homozygous for the Mlh1 gene are predisposed to developing tumors of the gastrointestinal (GI) tract, lymphomas, and a number of other tumor types. We also examined the role of adenomatous polyposis coli gene (Apc) gene mutations in the GI tumors of Mlh1 mutant mice by different methods and showed that the GI tumors in Mlh1 mice express little or no adenomatous polyposis coli protein. When an Apc gene mutation was bred into the Mlh1 mutant mice, the GI tumor incidence increased 40-100-fold. The wild-type Apc allele in these tumors was found to contain mutations. Together, these results show that we have developed two mouse models for human HNPCC and that the mechanisms of tumor development in the GI tract of these mice involve loss of Apc gene function in a manner very similar to that seen in the GI tumors of HNPCC.  (+info)

Review article: current status of gastrointestinal carcinoids. (6/1704)

Carcinoid tumours are enigmatic, slow growing malignancies which occur most frequently (74%) in the gastrointestinal tract. In recent years, it has become apparent that the term 'carcinoid' represents a wide spectrum of different neoplasms originating from a variety of different neuroendocrine cell types. Carcinoid lesions are usually identified histologically by their affinity for silver salts, by general neuroendocrine markers, or more specifically by immunocytochemistry using antibodies against their specific cellular products. Within the gut, the most frequent sites are the small bowel (29%), the appendix (19%) and rectum (13%). Clinical manifestations are often vague or absent. Nevertheless, in approximately 10% of patients the tumours secrete bioactive mediators which may engender various elements of characteristic carcinoid syndrome. In many instances the neoplasms are detected incidentally at the time of surgery for other gastrointestinal disorders. The tendency for metastatic spread correlates with tumour size, and is substantially higher in lesions larger than 2.0 cm. An association with noncarcinoid neoplasms is ascribed in 8-17% of lesions. Treatment consists of radical surgical excision of the tumour, although gastric (type I and II) and rectal carcinoids may be managed with local excision. Overall 5-year survival is excellent for carcinoids of the appendix (86%) and rectum (72%), whereas small intestinal (55%), gastric (49%) and colonic carcinoids (42%) exhibit a far worse prognosis.  (+info)

Treatment of upper abdominal malignancies with organ cluster procedures. (7/1704)

Upper abdominal exenteration for upper abdominal malignancies was carried out in 15 patients with removal of the liver, spleen, pancreas, duodendum, all or part of the stomach, proximal jejunum and ascending and transverse colon. Organ replacement was with the liver, pancreas and duodenum plus, in some cases, a short segment of jejunum. Eleven of the 15 patients survived for more than 4 months; 2 died, after 61/2 and 10 months, of recurrent tumor. Of the 9 patients who are surviving after 61/2 to 14 months, recurrent tumor is suspected in only 1 and proven in none. Four patients with sarcomas and carcinoid tumors (2 each) have had no recurrences. The other 5 survivors had duct cell cancers (3 examples), a cholangiocarcinoma (1 example), and a hepatoma (1 example). The experience so far supports further cautious trials with this drastic cancer operation.  (+info)

Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. (8/1704)

OBJECTIVE: To conduct a meta-analysis of 11 randomized controlled trials comparing enteral nutritional support supplemented with key nutrients versus standard enteral nutritional support to determine effects on morbidity and mortality rates and hospital stay. BACKGROUND DATA: Recent studies have shown that malnutrition occurs in up to 30% of patients undergoing gastrointestinal surgery, resulting in an increased risk of postoperative complications and death. With the realization that key nutrients can modulate inflammatory, metabolic, and immune processes, enteral nutritional regimens (supplemented with large amounts of key nutrients) have been developed for clinical use. METHODS: Eleven prospective, randomized controlled trials evaluating 1009 patients treated with combinations of key nutrients (Impact, Immun-Aid) were evaluated. Outcome measures examined were the incidences of pneumonia, infectious complications, and death, and length of hospital stay. Meta-analyses were undertaken to obtain the odds ratio and 95% confidence interval for incidences of infectious complications, pneumonia, and death, and the weighted mean difference and 95% confidence interval for length of hospital stay. RESULTS: The provision of nutritional support supplemented with key nutrients to patients with critical illness resulted in a decrease in infectious complications when compared with patients receiving standard nutritional support and a significant reduction in overall hospital stay. Similar results were documented in patients with gastrointestinal cancer. However, there were no differences between patient groups for either pneumonia or death. CONCLUSIONS: This meta-analysis has demonstrated that nutritional support supplemented with key nutrients results in a significant reduction in the risk of developing infectious complications and reduces the overall hospital stay in patients with critical illness and in patients with gastrointestinal cancer. However, there is no effect on death. These data have important implications for the management of such patients.  (+info)

Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery | Clinical Research...Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery | Clinical Research...
Clinical trial for Gastrointestinal Neoplasm , Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery
https://www.centerwatch.com/clinical-trials/listings/177596/gastrointestinal-neoplasms-clinical-trial-on-acupuncture/?radius=50
Sentinel lymph node mapping with GI cancer<...
TY - JOUR. T1 - Sentinel lymph node mapping with GI cancer. AU - Aikou, Takashi. AU - Kitagawa, Yuko. AU - Kitajima, Masaki. AU - Uenosono, Yoshikazu. AU - Bilchik, Anton J.. AU - Martinez, Steve R.. AU - Saha, Sukamal. PY - 2006/6. Y1 - 2006/6. N2 - Precise evaluation of lymph node status is one of the most important factors in determining clinical outcome in treating gastro-intestinal (GI) cancer. Sentinel lymph node (SLN) mapping clearly has become highly feasible and accurate in staging GI cancer. The lunchtime symposium focused on the present status of SLN mapping for GI cancer. Dr. Kitigawa proposed a new strategy using sentinel node biopsy for esophageal cancer patients with clinically early stage disease. Dr. Uenosono reported on whether the SLN concept is applicable for gastric cancer through his analysis of more than 180 patients with cT1-2, N0 tumors. The detection rate was 95%, the false negative rate of lymph node metastasis including micro-metastasis was 4%, and accuracy was 99% in ...
https://ucdavis.pure.elsevier.com/en/publications/sentinel-lymph-node-mapping-with-gi-cancer
Cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in advanced gastrointestinal cancer<...
TY - JOUR. T1 - Cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in advanced gastrointestinal cancer. AU - Scanni, A.. AU - Tomirotti, M.. AU - Margulis, A.. AU - Biraghi, M.. AU - Curtarelli, G.. PY - 1979. Y1 - 1979. N2 - The effectiveness of the cyclophosphamide + methotrexate + 5-fluorouracil schedule (CMF) in 28 patients with advanced gastrointestinal cancer has been studied. No complete remission was obtained; partial remission and objective improvement constituted 56%. The median response period is calculated at a minimum of 12 months, without significant differences between the group of patients previously subjected to palliative canalization surgery and the group of patients not subjected to this operation. The overall median survival time is 10.8 months. On the basis of the data given, the authors conclude by stressing that the CMF combination should be studied more fully in relation to its use in gastrointestinal forms of cancer.. AB - The effectiveness of the cyclophosphamide + ...
https://moh-it.pure.elsevier.com/en/publications/cyclophosphamide-methotrexate-5-fluorouracil-cmf-in-advanced-gast
2012. ISPOR European Congress - Cost-Effectiveness Analysis of Immunonutrition for Upper Gastrointestinal Cancer Patients...2012. ISPOR European Congress - Cost-Effectiveness Analysis of Immunonutrition for Upper Gastrointestinal Cancer Patients...
Chevrou-Severac H, Eijgelshoven I, Weijers L. Cost-Effectiveness Analysis of Immunonutrition for Upper Gastrointestinal Cancer Patients Undergoing Surgery in British Hospitals. Value Health. 2012 Nov;15(7):A416. Presented at: ISPOR 15th Annual European Congress; November 6, 2012; Berlin, Germany.. ...
https://mapi-trust.org/posters/cost-effectiveness-analysis-immunonutrition-upper-gastrointestinal-cancer-patients-undergoing-surgery-british-hospitals/
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer - Full Text View -...Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer - Full Text View -...
RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.. PURPOSE: This phase I trial is studying the side effects and best dose of irinotecan when given together with fluorouracil and leucovorin in treating patients with advanced gastrointestinal cancer. ...
https://clinicaltrials.gov/ct2/show/NCT00654160
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer - Full Text View -...Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer - Full Text View -...
RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.. PURPOSE: This phase I trial is studying the side effects and best dose of irinotecan when given together with fluorouracil and leucovorin in treating patients with advanced gastrointestinal cancer. ...
https://clinicaltrials.gov/ct2/show/study/NCT00654160?view=results
Gastrointestinal (GI) Cancer Treatment Program | Danbury HospitalGastrointestinal (GI) Cancer Treatment Program | Danbury Hospital
Danbury Hospitals Gastrointestinal (GI) Cancer Program offers a variety plans for the best personalized care. Learn about gastrointestinal (GI) cancer treatment here.
https://www.danburyhospital.org/departments/gastrointestinal-gi-cancer-program-at-western-connecticut-health-network-danbury/gi-cancer-program/~/link.aspx?_id=78D59D9E5620422B98E1249A9A078941&_z=z
Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells<...
TY - JOUR. T1 - Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells. AU - Vangamudi, Bhavatarini. AU - Zhu, Shoumin. AU - Soutto, Mohammed. AU - Belkhiri, Abbes. AU - El-Rifai, Wael. PY - 2011/3/29. Y1 - 2011/3/29. N2 - Background: Truncated dopamine and cyclic-AMP-regulated phosphoprotein (t-DARPP) is frequently overexpressed in gastrointestinal malignancies. In this study, we examined the role of t-DARPP in regulating β-catenin.Results: The pTopFlash construct that contains multiple TCF/LEF-binding sites was used as a measure of β-catenin/TCF transcription activity. Gastric (AGS, MKN28) and esophageal (FLO-1) adenocarcinoma cancer cell lines that lack t-DARPP expression were utilized to establish stable and transient in vitro expression models of t-DARPP. The expression of t-DARPP led to a significant induction of the pTOP reporter activity, indicative of activation of β-catenin/TCF nuclear signaling. Immunofluorescence assays supported this finding and showed ...
https://miami.pure.elsevier.com/en/publications/regulation-of-%CE%B2-catenin-by-t-darpp-in-upper-gastrointestinal-canc
Vitamin D and the Epidemiology of Upper Gastrointestinal Cancers: A Critical Analysis of the Current Evidence | Cancer...Vitamin D and the Epidemiology of Upper Gastrointestinal Cancers: A Critical Analysis of the Current Evidence | Cancer...
Prospective analyses have yet to uncover a consistent relationship between vitamin D status and incidence and mortality of rarer cancers including esophageal and upper gastrointestinal cancers. We searched PubMed for literature about the epidemiology of upper gastrointestinal cancers and vitamin D published over the last decade and then summarized and critiqued the results of these studies in this review. The search yielded nine relevant studies. Overall, no consistent relationship was reported between serum vitamin D levels or a surrogate and upper gastrointestinal cancers. Four studies reported negative correlations between vitamin D status and upper gastrointestinal cancer, three reported positive correlations, one reported no correlation, and one reported both positive and negative correlations. No relationship has been established on the basis of epidemiologic data, but studies examining sun exposure consistently report an inverse association with esophageal cancer. The current literature ...
http://cebp.aacrjournals.org/content/22/6/1007.short?rss=1
2015 GI Cancers Symposium - Thursday - ASCO2015 GI Cancers Symposium - Thursday - ASCO
Ronald Levy, MD, receiving the keynote plaque and presenting his talk, Immune Checkpoints for Upper Gastrointestinal Cancers. San Francisco, CA - 2015 Gastrointestinal Cancers Symposium - San Francisco, CA: Ronald Levy, MD, receiving the keynote plaque and presenting his talk, Immune Checkpoints for Upper Gastrointestinal Cancers during Keynote Lecture: Immune Checkpoints For Upper Gastrointestinal Cancers at the Gastrointestinal Cancers Symposium 2015 here today, Thursday January 15, 2015. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, The American Society of Radiation Oncology, SSO, Society of Surgical Oncology and the AGA Institute. Over 3,000 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Moscone West center in San Francisco and features the latest Gastrointestinal Cancers research in the areas of basic and clinical science. Date: Thursday January 15, 2015. Photo by © ASCO/Todd ...
https://photos.asco.org/ASCO-Public-1/2015-GI-Symposium/2015-ASCO-GI-Public-Thursday/i-vtbBHP5
Combined Therapy for Gastrointestinal Carcinomas: Exploiting Synergies Between Gene Therapy and Classical Chemo-Radiotherapy |...Combined Therapy for Gastrointestinal Carcinomas: Exploiting Synergies Between Gene Therapy and Classical Chemo-Radiotherapy |...
Title:Combined Therapy for Gastrointestinal Carcinomas: Exploiting Synergies Between Gene Therapy and Classical Chemo-Radiotherapy. VOLUME: 15 ISSUE: 2. Author(s):Mariana Malvicini, Jorge B. Aquino and Guillermo Mazzolini. Affiliation:Liver Unit, Facultad de Ciencias Biomedicas. Universidad Austral, Avenida Presidente Peron 1500 (B1629ODT) Derqui-Pilar, Buenos Aires, Argentina.. Keywords:Gastrointestinal, cancer, gene therapy, combined strategies, chemotherapy, radiotherapy, immunotherapy.. Abstract:Surgical resection is the only curative option for patients with gastrointestinal carcinomas. Unfortunately, the majority of patients are diagnosed in advanced stages when surgery is not possible. Moreover, the incidence and mortality for certain type of tumors such as hepatocellular carcinoma or pancreatic cancer are steadily increasing worldwide. In spite of the advances in the development of molecular targeted therapies for cancer, the impact on patient survival has been rather limited. It is ...
http://www.eurekaselect.com/127111/article?tracking-code=4
Gastrointestinal Carcinoma 2009
17 MartThis gastrointestinal carcinoma 2009 means the best for marijuana 2 socialism system. They hear not enjoy millions. I ve that this part took me sit it. 2 MartGOLD USMLE focus 2CS Review accepts described also nineteenth for me. Each gastrointestinal a short MANAGER is used. Since 2004, the Foundation is hieroglyphs for the Voluntary Social Year in Culture( German: Freiwillige Soziale Jahr in der Kultur or FSJ), a origin of National Service for options and enigmatic systems who situate advanced video publications. There is a world each at the quality of the Berlin State Museums, Ibero-American Institute, Berlin State Library and the Central Archive of the Berlin State Museums. The Heritage Foundation certainly has Revisions for relationship to interchangeable intensity and mode channels in Berlin. mean you are that this gastrointestinal carcinoma 2009 does a information? Unlimited FREE Two-Day Shipping, no Mexican spread and more. international records are Free Two-Day Shipping, Free ...
http://mibusinc.com/photos/SamburuandtheMasaiMara/freebooks/gastrointestinal-carcinoma-2009/
Update: Hereditary syndromes in GI cancer: Who should be tested and why?Update: Hereditary syndromes in GI cancer: Who should be tested and why?
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Zsofia K. Stadler assesses the state of knowledge regarding hereditary syndromes in GI cancer, and proffers who should be tested and why. Earn CME Credit for a related activity: http://elc.imedex.com/ELC/S... © 2017 Imedex, LLC.
https://www.oncologytube.com/video/update-hereditary-syndromes-in-gi-cancer-who-should-be-tested-and-why/10002093
JCI - Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytesJCI - Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
Tumor-resident lymphocytes can mount a response against neoantigens expressed in microsatellite-stable gastrointestinal (GI) cancers, and adoptive transfer of neoantigen-specific lymphocytes has demonstrated antitumor activity in selected patients. However, whether peripheral blood could be used as an alternative minimally invasive source to identify lymphocytes targeting neoantigens in patients with GI cancer with relatively low mutation burden is unclear. We used a personalized high-throughput screening strategy to investigate whether PD-1 expression in peripheral blood could be used to identify CD8+ or CD4+ lymphocytes recognizing neoantigens identified by whole-exome sequencing in 7 patients with GI cancer. We found that neoantigen-specific lymphocytes were preferentially enriched in the CD8+PD-1+/hi or CD4+PD-1+/hi subsets, but not in the corresponding bulk or PD-1- fractions. In 6 of 7 individuals analyzed we identified circulating CD8+ and CD4+ lymphocytes targeting 6 and 4 neoantigens, ...
https://www.jci.org/articles/view/127967/table/1
UPMC Physician Resources: Gastroenterology and Hepatology State of the Art Lecture: Genetic Susceptibility to GI CancersUPMC Physician Resources: Gastroenterology and Hepatology State of the Art Lecture: Genetic Susceptibility to GI Cancers
Good morning. So we are going to talk about genetic susceptibility to GI cancers today. As Dr. Brand just said, the first part will be about colon syndromes and then hell talk to you a little bit about pancreatic syndromes as well. So this is interactive, Im going to give you guys some case scenarios and ask you to tell me what you think the genetic syndrome is. So please participate.. All right. So just a little bit of an overview for you first. This is information that you may already know but just if you are seeing a patient and thinking about whether or not they may have a hereditary predisposition to cancer these are the sorts of things that you would want to keep in mind. So young age of cancer diagnosis, typically before age 50; if there are multiple people that have either the same or genetically related types of cancer; people with more than one cancer diagnosis; people with unusual types of cancer; and then of course from a colon perspective people who have lots and lots of colon ...
http://www.upmcphysicianresources.com/cme-course/gastroenterology-and-hepatology-state-of-the-art-lecture-genetic-susceptibility-to-gi-cancers
Global Gastrointestinal Cancer Drugs Market Research Report 2017 Opportunities, Product Types, Applications, Forecast to 2022
Global Gastrointestinal Cancer Drugs Market Professional Survey Report 2017 1 Industry Overview of Gastrointestinal Cancer Drugs 1.1 Definition and Specifications of Gastrointestinal Cancer Drugs 1.1.1 Definition of Gastrointestinal Cancer Drugs 1.1.2 Specifications of Gastrointestinal Cancer Drugs 1.2 Classification of Gastrointestinal Cancer Drugs 1.2.1 Immunotherapy 1.2.2 Chemotherapy 1.2.3 Targeted Therapy 1.2.4 Hormone Therapy 1.2.5 Adjuvant Chemotherapy 1.2.6 Radiation Therapy 1.2.7 Others 1.3 Applications of Gastrointestinal Cancer Drugs 1.3.1 Hospitals 1.3.2 Specialized Cancer Treatment Centers 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 2 Manufacturing Cost Structure Analysis of Gastrointestinal Cancer Drugs 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Gastrointestinal Cancer Drugs 2.3 Manufacturing Process Analysis of ...
https://www.marketdeeper.com/global-gastrointestinal-cancer-drugs-market-research-report-2017-7480.html
Diagnostic Accuracy of Age and Alarm Symptoms for Upper GI Malignancy in Patients with Dyspepsia in a GI Clinic: A 7-Year Cross...Diagnostic Accuracy of Age and Alarm Symptoms for Upper GI Malignancy in Patients with Dyspepsia in a GI Clinic: A 7-Year Cross...
Objectives We investigated whether using demographic characteristics and alarm symptoms can accurately predict cancer in patients with dyspepsia in Iran, where upper GI cancers and H. pylori infection are common. Methods All consecutive patients referred to a tertiary gastroenterology clinic in Tehran, Iran, from 2002 to 2009 were invited to participate in this study. Each patient completed a standard questionnaire and underwent upper gastrointestinal endoscopy. Alarm symptoms included in the questionnaire were weight loss, dysphagia, GI bleeding, and persistent vomiting. We used logistic regression models to estimate the diagnostic value of each variable in combination with other ones, and to develop a risk-prediction model. Results A total of 2,847 patients with dyspepsia participated in this study, of whom 87 (3.1%) had upper GI malignancy. Patients reporting at least one of the alarm symptoms constituted 66.7% of cancer patients compared to 38.9% in patients without cancer (p|0.001). Esophageal
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0039173
2015 GI Cancers Symposium - Saturday - ASCO2015 GI Cancers Symposium - Saturday - ASCO
Speakers and attendees. San Francisco, CA - 2015 Gastrointestinal Cancers Symposium : Speakers and attendees during Guidelines for Colorectal Cancer Management-How They Are Established and How They Differ at the Gastrointestinal Cancers Symposium 2015 here today, Saturday January 17, 2015. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, The American Society of Radiation Oncology, SSO, Society of Surgical Oncology and the AGA Institute. Over 3,000 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Moscone West center in San Francisco and features the latest Gastrointestinal Cancers research in the areas of basic and clinical science. Date: Saturday January 17, 2015. Photo by © ASCO/Todd Buchanan 2015 Technical Questions: [email protected]; Phone: 612-226-5154. GI15_Roundtables. 15GI05028GI15_Roundtables ...
https://photos.asco.org/ASCO-Public-1/2015-GI-Symposium/2015-ASCO-GI-Public-Saturday/i-sQjQx42/
Chemoprevention of Low-Molecular-Weight Citrus Pectin (LCP) in Gastrointestinal Cancer Cells [Abstract]Chemoprevention of Low-Molecular-Weight Citrus Pectin (LCP) in Gastrointestinal Cancer Cells [Abstract]
Abstract. Background & Aims: Low-molecular-weight citrus pectin (LCP) is a complex polysaccharide that displays abundant galactosyl (i.e., sugar carbohydrate) residues. In this study, we evaluated the anti-tumor properties of LCP that lead to Bcl-xL -mediated dampening of apoptosis in gastrointestinal cancer cells.. Methods: We used AGS gastric cancer and SW-480 colorectal cancer cells to elucidate the effects of LCP on cell viability, cell cycle and apoptosis in cultured cells and tumor xenografts.. Results: Significantly decreased cell viabilities were observed in LCP treated AGS and SW-480 cells (P,0.05). Cell cycle-related protein expression, such as Cyclin B1, was also decreased in LCP treated groups as compared to the untreated group. The AGS or SW-480 cell-line tumor xenografts were significantly smaller in the LCP treated group as compared the untreated group (P,0.05). LCP treatment decreased Galectin-3 (GAL-3) expression levels, which is an important gene in cancer metastasis that ...
http://www.ijbs.com/v12p0746
Lower Gastrointestinal Malignancies -9781933864921|Demos Medical PublishingLower Gastrointestinal Malignancies -9781933864921|Demos Medical Publishing
Lower Gastrointestinal Malignancies|Lower Gastrointestinal MalignanciesThis issue of Radiation Medicine Rounds focuses on lower gastrointestinal malignancies.
http://www.springerpub.com/lower-gastrointestinal-malignancies.html
Omega-3 fatty acid supplementation improves immune function, lowers inflammation in gastrointestinal cancer patients - Life...Omega-3 fatty acid supplementation improves immune function, lowers inflammation in gastrointestinal cancer patients - Life...
A review and meta-analysis appearing in the April 2018 issue of the journal Medicine concluded that supplementation with omega-3 polyunsaturated fatty acids early in the treatment of gastrointestinal cancer can boost immune function and reduce inflammation.
https://www.lifeextension.com/Newsletter/2018/6/Omega-3-supplementation-improves-immune-function-in-gastrointestinal-cancer-patients?sourcecode=EZXX00E&utm_source=eNewsletter&utm_medium=email&utm_content=HeroTitle&utm_campaign=EZXX00E
Gastrointestinal Cancer Symptoms | Tampa General HospitalGastrointestinal Cancer Symptoms | Tampa General Hospital
Gastrointestinal cancer symptoms vary widely because cancer can affect the esophagus, stomach, liver and many other parts of the GI system. Read more here.
https://www.tgh.org/services/cancer/types-cancer/gastrointestinal-cancer/gastrointestinal-cancer-symptoms
DCE-CT in the follow-up of targeted therapy in GISTs - Danish National Research Database-Den Danske ForskningsdatabaseDCE-CT in the follow-up of targeted therapy in GISTs - Danish National Research Database-Den Danske Forskningsdatabase
Contrast Media; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Molecular Targeted Therapy; Positron-Emission Tomography; Tomography, X-Ray Computed ...
http://www.forskningsdatabasen.dk/catalog/244742995
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of tumor cells, eithe
http://www.knowcancer.com/cancer-trials/NCT00654160/
Pittsburg State University / ALL
The therapeutic landscape in oncology has undergone momentous changes in recent years. The treatment options for gastrointestinal (GI) cancers, in particular, have increased with the introduction of novel pharmacological and other treatment modalities. Researchers have gleaned important insights into the molecular biology, pathophysiology and key features of the most prevalent GI cancers, including colorectal, pancreatic and liver. While these advances have resulted in improvements for many GI cancer patients, the emerging complexities and challenges have necessitated the revision of major U.S ...
http://kids-sierra.pittstate.edu/search~S1?/dCancer+--+Etiology./dcancer+etiology/-3%2C1%2C1%2CB/frameset&FF=dcancer+gastrointestinal+system+handbooks+manuals+etc&1%2C1%2C
JCI - WelcomeJCI - Welcome
Tumor-resident lymphocytes can mount a response against neoantigens expressed in microsatellite-stable gastrointestinal (GI) cancers, and adoptive transfer of neoantigen-specific lymphocytes has demonstrated antitumor activity in selected patients. However, whether peripheral blood could be used as an alternative minimally invasive source to identify lymphocytes targeting neoantigens in patients with GI cancer with relatively low mutation burden is unclear. We used a personalized high-throughput screening strategy to investigate whether PD-1 expression in peripheral blood could be used to identify CD8+ or CD4+ lymphocytes recognizing neoantigens identified by whole-exome sequencing in 7 patients with GI cancer. We found that neoantigen-specific lymphocytes were preferentially enriched in the CD8+PD-1+/hi or CD4+PD-1+/hi subsets, but not in the corresponding bulk or PD-1- fractions. In 6 of 7 individuals analyzed we identified circulating CD8+ and CD4+ lymphocytes targeting 6 and 4 neoantigens, ...
https://jci.org/tags/33
Most recent papers with the keyword Total parenteral nutrition | Read by QxMDMost recent papers with the keyword Total parenteral nutrition | Read by QxMD
BACKGROUND AND OBJECTIVES: Omega-3 fatty acids are widely used in nutritional support. However, whether parenteral supplementation with ω-3 fatty acids is effective for gastrointestinal cancer patients remains uncertain. This study assessed the effects of this form of parenteral nutrition on immune function and clinical outcomes in postoperative gastrointestinal cancer patients. METHODS AND STUDY DESIGN: We searched Medline, Embase, Scopus, and the reference lists of selected studies to identify randomized controlled trials that compared ω-3 fatty acids with a control, and that included immune indices, infectious complications, or length of hospital stay in the final outcomes ...
https://www.readbyqxmd.com/keyword/29436
BeatingCancerCenter - The Di Bella Method - A randomised trial of octreotide vs best supportive care only in advanced...BeatingCancerCenter - The Di Bella Method - A randomised trial of octreotide vs best supportive care only in advanced...
Your Body: Gods Temple: Dangerous ingredient in store-bought almond milk (almost all of them) and most soy milk (including...Your Body: Gods Temple: Dangerous ingredient in store-bought almond milk (almost all of them) and most soy milk (including...
In this article I review the association between exposure to carrageenan and the occurrence of colonic ulcerations and gastrointestinal neoplasms in animal models. Although the International Agency for Research on Cancer in 1982 identified sufficient evidence for the carcinogenicity of degraded carrageenan in animals to regard it as posing a carcinogenic risk to humans, carrageenan is still used widely as a thickener, stabilizer, and texturizer in a variety of processed foods prevalent in the Western diet. I reviewed experimental data pertaining to carrageenans effects with particular attention to the occurrence of ulcerations and neoplasms in association with exposure to carrageenan. In addition, I reviewed from established sources mechanisms for production of degraded carrageenan from undegraded or native carrageenan and data with regard to carrageenan intake. Review of these data demonstrated that exposure to undegraded as well as to degraded carrageenan was associated with the occurrence of ...
http://yourbodygodstemple.blogspot.com/2009/10/dangerous-ingredient-in-store-bought.html
Microbial community profiling of human gastrointestinal cancersMicrobial community profiling of human gastrointestinal cancers
The human microbiome - defined as the microbial communities that live in and on our bodies - is emerging as a key factor in human diseases. The expanding research field that investigates the role of the...
https://teses.usp.br/teses/disponiveis/95/95131/tde-07022019-134344/pt-br.php
A Phase 1, Open-Label Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas...A Phase 1, Open-Label Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas...
This phase I trial will investigate MT 111 [MEDI 565; MedImmune], a BiTE antibody, in patients with advanced gastrointestinal cancer. Safety, tolerability and
http://adisinsight.springer.com/trials/700060218?error=cookies_not_supported&code=9a7e8943-66ab-46ba-b747-1c520ae05f45
Crosstalk between the Notch signaling pathway and non‑coding RNAs in gastrointestinal cancers (Review)Crosstalk between the Notch signaling pathway and non‑coding RNAs in gastrointestinal cancers (Review)
The Notch signaling pathway is one of the main signaling pathways that mediates direct contact between cells, and is essential for normal development. It regulates various cellular processes, including cell proliferation, apoptosis, migration, invasion, angiogenesis and metastasis. It additionally serves an important function in tumor progression. Non‑coding RNAs mainly include small microRNAs, long non‑coding RNAs and circular RNAs. At present, a large body of literature supports the biological significance of non‑coding RNAs in tumor progression. It is also becoming increasingly evident that cross‑talk exists between Notch signaling and non‑coding RNAs. The present review summarizes the current knowledge of Notch‑mediated gastrointestinal cancer cell processes, and the effect of the crosstalk between the three major types of non‑coding RNAs and the Notch signaling pathway on the fate of gastrointestinal cancer cells ...
https://www.spandidos-publications.com/ol/15/1/31/abstract
p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses<...
TY - JOUR. T1 - p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses. AU - Hardwick, Nicola R.. AU - Carroll, Mary. AU - Kaltcheva, Teodora. AU - Qian, Dajun. AU - Lim, Dean. AU - Leong, Lucille. AU - Chu, Peiguo. AU - Kim, Joseph. AU - Chao, Joseph. AU - Fakih, Marwan. AU - Yen, Yun. AU - Espenschied, Jonathan. AU - Ellenhorn, Joshua D.I.. AU - Diamond, Don J.. AU - Chung, Vincent. PY - 2014/9/1. Y1 - 2014/9/1. N2 - PURPOSE: To conduct a phase I trial of a modified vaccinia Ankara (MVA) vaccine delivering wild-type human p53 (p53MVA) in patients with refractory gastrointestinal cancers.EXPERIMENTAL DESIGN: Three patients were vaccinated with 1.0×10(8) plaque-forming unit (pfu) p53MVA followed by nine patients at 5.6×10(8) pfu. Toxicity was classified using the NCI Common Toxicity Criteria and clinical responses were assessed by CT scan. Peripheral blood samples were collected pre- and post-immunization for immunophenotyping, ...
https://tmu.pure.elsevier.com/zh/publications/p53mva-therapy-in-patients-with-refractory-gastrointestinal-malig-2
Cancers | Free Full-Text | EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCCCancers | Free Full-Text | EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC
Reply. We went through this section and sharpen our statements. But, we included a new point into our conclusion since reviewer 1 requested a more critical view on the question: did EV based liquid biopsy make the translational step forward at least from bench to bed side, at least in some diagnostic applications. Unfortunately, not really and actually it is the current Achilles heel of the whole EV based experimental diagnosis. I discussed this in the conclusion citing appropriate references and referring to FDA. Reviewer 3 Report. The review article by Artur et al. EVs as potential new therapeutic tool/target in gastrointestinal and HCC describes and summarizes body of literature on EVs and their involvement in GI cancers and HCC. The field of EVs and their potential role as tumor biomarker and potential therapeutic target in different cancers has received considerable attention in recent years. The authors have accumulated and described literature focused on EVs in GI cancers and HCC. I ...
https://www.mdpi.com/2072-6694/12/10/3019/review_report
PA-07-256: Immunoregulation of Gastrointestinal Carcinogenesis (R01)PA-07-256: Immunoregulation of Gastrointestinal Carcinogenesis (R01)
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Immunoregulation of Gastrointestinal Carcinogenesis (R01) PA-07-256. NCI
https://grants.nih.gov/grants/guide/pa-files/PA-07-256.html
Gastrointestinal Neoplasia in Horses - Symptoms, Causes, Diagnosis, Treatment, Recovery, Management, CostGastrointestinal Neoplasia in Horses - Symptoms, Causes, Diagnosis, Treatment, Recovery, Management, Cost
Chronic weight loss may indicate the disease condition known as gastrointestinal neoplasia which is an aggressive cancerous growth within the digestive tract and stomach. - Wag! (formerly Vetary)
https://wagwalking.com/horse/condition/gastrointestinal-neoplasia
The use of DNA fingerprinting to resolve conflicting results in patients with suspected gastrointestinal malignancy<...
TY - JOUR. T1 - The use of DNA fingerprinting to resolve conflicting results in patients with suspected gastrointestinal malignancy. AU - Islam, Sameer. AU - Miller, Ethan D.. AU - Patel, Neal. AU - De Petris, Giovanni. AU - Highsmith, Edward W.. AU - Fleischer, David E.. PY - 2013/3/1. Y1 - 2013/3/1. N2 - GOALS: To underscore the utility of DNA fingerprinting for clarifying disparate results from endoscopic pathologic specimens. BACKGROUND: Occasionally, serially obtained gastrointestinal biopsies may yield inconsistent results. These discrepancies pose a dilemma for gastroenterologists and their patients, especially when malignancy is a consideration. STUDY: Patients referred to our tertiary care center from outside institutions had undergone endoscopically obtained esophageal biopsies showing malignancy, verified by pathologists at both our site and from the referring center. Repeat endoscopic biopsies at our center did not show malignancy. To verify that different sets of biopsies came from ...
https://mayoclinic.pure.elsevier.com/en/publications/the-use-of-dna-fingerprinting-to-resolve-conflicting-results-in-p
Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatmentRisk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment
Gastrointestinal malignancies may be associated with obesity, defined specifically by increased body-mass index, and based largely on environmental factors rather than genetics. In particular, there seems to be a definite increase in the incidence of both oesophageal and colorectal cancer. Mechanism …
https://pubmed.ncbi.nlm.nih.gov/15561645/?dopt=Abstract
Oncology Self-Study: Head and Neck Cancers, GI Cancers | ASCO ConnectionOncology Self-Study: Head and Neck Cancers, GI Cancers | ASCO Connection
Test your knowledge of head and neck cancers and gastrointestinal cancers with questions from a past edition of ASCO-SEP®, ASCOs self-evaluation program in oncology.
https://connection.asco.org/tec/oncology-self-study/oncology-self-study-head-and-neck-cancers-gi-cancers
Dr. Marshall Discusses the State of RAS Mutations in GI CancersDr. Marshall Discusses the State of RAS Mutations in GI Cancers
John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, discusses the current state of RAS-mutant gastrointestinal (GI) cancers during the 2017 Ruesch Center Symposium.|br /|  
http://www.onclive.com/onclive-tv/dr-marshall-discusses-the-state-of-ras-mutations-in-gi-cancers
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed...Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed...
New life-saving treatments for Carcinoid tumors | gastrointestinal neoplasms | neuroendocrine tumors in clinical trial on Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
http://www.centerwatch.com/clinical-trials/listings/98694/neuroendocrine-tumors-study-lanreotide-patients-metastatic/?&radius=50
Stages of gastrointestinal neuroendocrine tumours (GI NETs) - Canadian Cancer SocietyStages of gastrointestinal neuroendocrine tumours (GI NETs) - Canadian Cancer Society
Many gastrointestinal neuroendocrine tumours (GI NETs) are staged differently than other types of GI cancer. These include NETs of the: stomach small intestine and ampulla of Vater colon and rectum (also called the large intestine)appendix (not part of the GI tract, but often grouped with GI organs)
https://www.cancer.ca/en/cancer-information/cancer-type/neuroendocrine/staging/gastrointestinal-tumours/?region=ns
What Are the Risk Factors for Gastrointestinal Carcinoid Tumors?What Are the Risk Factors for Gastrointestinal Carcinoid Tumors?
Many risk factors may increase your chance of developing gastrointestinal carcinoid tumors. This guide will help you learn about possible causes of gastrointestinal carcinoid tumors.
https://www.cancer.org/cancer/gastrointestinal-carcinoid-tumor/causes-risks-prevention/risk-factors.html
Chromogranin a in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: A large series from...
TY - JOUR. T1 - Chromogranin a in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms. T2 - A large series from a single institution. AU - Massironi, Sara. AU - Rossi, Roberta Elisa. AU - Casazza, Giovanni. AU - Conte, Dario. AU - Ciafardini, Clorinda. AU - Galeazzi, Marianna. AU - Peracchi, Maddalena. PY - 2014/2/6. Y1 - 2014/2/6. N2 - Background/Aims: Plasma chromogranin A (CgA) is the most widely used biochemical biomarker in the diagnostic workup and follow-up of gastroenteropancreatic neuroendo- crine neoplasms (GEP-NENs). Herein, we assessed the clinical utility of CgA in diagnosing and monitoring a large series of GEP-NENs. Patients and Methods: A total of 181 GEP-NEN patients (87 males, 94 females) with pancreatic (n = 81) and gastrointestinal neoplasms (n = 100) were included; 99 patients had grade (G)1 NENs (Ki-67 ≤2%), 57 G2 NENs (Ki-67 3-20%) and 25 G3 NENs (Ki-67 ,20%); 81 patients had tumor-node-metastasis (TNM) stage I, 14 stage II, 17 stage ...
https://moh-it.pure.elsevier.com/en/publications/chromogranin-a-in-diagnosing-and-monitoring-patients-with-gastroe
Gastrointestinal carcinoid tumors | Carcinoid complete resection. Surgery: Treatment in Germany, Tuebingen hospitals on...Gastrointestinal carcinoid tumors | Carcinoid complete resection. Surgery: Treatment in Germany, Tuebingen hospitals on...
Gastrointestinal carcinoid tumors | Carcinoid complete resection. Surgery: Treatment in Tuebingen, Germany ✈. Prices on BookingHealth.com - booking treatment online!
https://bookinghealth.com/programs/treatment/surgery/gastrointestinal-carcinoid-tumors-tumors-carcinoid-complete-/germany/tuebingen
Gastrointestinal carcinoid tumors. Gastroenterology: Diagnostic in Germany, Hamburg hospitals on BookingHealth.comGastrointestinal carcinoid tumors. Gastroenterology: Diagnostic in Germany, Hamburg hospitals on BookingHealth.com
Gastrointestinal carcinoid tumors. Gastroenterology: Diagnostic in Hamburg, Germany ✈. Prices on BookingHealth.com - booking treatment online!
https://bookinghealth.com/programs/diagnostic/gastroenterology/gastrointestinal-carcinoid-tumors/germany/hamburg
Synchronous Gastrointestinal Carcinoid Tumor and Colon Adenocarcinoma: Case Reports and Literature Review - Order reprints ...Synchronous Gastrointestinal Carcinoid Tumor and Colon Adenocarcinoma: Case Reports and Literature Review - Order reprints ...
Synchronous Gastrointestinal Carcinoid Tumor and Colon Adenocarcinoma: Case Reports and Literature Review - Order reprints #903580
https://www.amjcaserep.com/reprintOrder/index/idArt/903580
Treatment of Gastrointestinal Carcinoid Tumors by StageTreatment of Gastrointestinal Carcinoid Tumors by Stage
For gastrointestinal carcinoid tumors that have not spread to distant sites, surgery is usually the primary or first treatment. Learn about other treatment options here.
https://www.cancer.org/cancer/gastrointestinal-carcinoid-tumor/treating/by-stage.html
Gastrointestinal Carcinoid Imaging: Practice Essentials, Radiography, Computed TomographyGastrointestinal Carcinoid Imaging: Practice Essentials, Radiography, Computed Tomography
Gastrointestinal carcinoid, also called carcinoid tumor, is the most common primary tumor of the small bowel and appendix. Gastrointestinal carcinoid accounts for more than 95% of all carcinoids.
https://emedicine.medscape.com/article/364581-overview
Tekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference Nasdaq:ABUSTekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference Nasdaq:ABUS
New Data Shows Positive Chromogranin-A Biomarker Results in GI-NET Patient. Phase I/II Clinical Trial with TKM-PLK1 Ongoing in Patients with Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC). VANCOUVER, British Columbia, Oct. 4, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that it presented additional TKM-PLK1 data at the 6th Annual NET Conference hosted by the North American Neuroendocrine Tumor Society (NA-NETS) to be held in Charleston, South Carolina from October 4-5, 2013.. We are pleased to present data at this conference reaching researchers and physicians treating patients who have been diagnosed with neuroendocrine tumors. We have an ongoing Phase I/II clinical trial with TKM-PLK1, with current enrollment targeting patients with either advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC), ...
http://www.globenewswire.com/news-release/2013/10/04/578201/10051243/en/Tekmira-Presents-TKM-PLK1-Data-at-6th-Annual-North-American-Neuroendocrine-Tumor-Society-NA-NETS-Conference.html
A case of malignant gastrointestinal stromal tumor of the uncommitted type<...
TY - JOUR. T1 - A case of malignant gastrointestinal stromal tumor of the uncommitted type. AU - Hayama, Satoshi. AU - Yabiku, Takashi. AU - Takenouchi, Nobuo. AU - Kato, Hiroyuki. AU - Nishihara, Hiroshi. PY - 2001/1/1. Y1 - 2001/1/1. N2 - We report a case of gastrointestinal stromal tumor (GIST) with peritoneal dissemination. A 73-year-old man was diagnosed to have a lesion of the stomach by an upper gastrointestinal barium study at an annual physical examination. Subsequently, melena was recognized and the patient was referred to our hospital. Gastrointestinal endoscopy revealed a huge submucosal tumor extending from the gastric body to the fundus which was ulcerated and hemorrhagic. Under the suspected diagnosis of the huge submucosal tumor of malignancy, total gastrectomy, splenectomy, pancreatectomy, and D2 dissection were performed. During the operation, another mass was found on the serosa of the sigmoid colon and resected. Histological examination revealed that the tumor was a GIST of ...
https://keio.pure.elsevier.com/en/publications/a-case-of-malignant-gastrointestinal-stromal-tumor-of-the-uncommi
A population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours - Canadian Journal of SurgeryA population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours - Canadian Journal of Surgery
Contexte : Les tumeurs neuroendocrines (TNE) sont hétérogènes, et les tableaux et options thérapeutiques sont variables. À notre connaissance, il nexiste pas détudes randomisées et il y a peu détudes à long terme sur les résultats chez les patients. Le rôle du traitement chirurgical et médicamenteux de la maladie locale, régionale et métastatique continue dêtre évalué dans la littérature.. Méthodes : Nous avons procédé à une interrogation démographique du Registre provincial du cancer pour recenser les patients atteints de TNE gastro-intestinales provenant de lestomac, de lintestin grêle, du côlon et du rectum, diagnostiqués entre 1990 et 2005 et nous avons évalué les résultats.. Résultats : Nous avons examiné les données clinico-pathologiques des résultats enregistrés chez 530 patients atteints de TNE gastro-intestinales. Lincidence globale des TNE a augmenté de 11 par million à 19 par million pendant la période de létude. Le stade de la maladie et ...
http://canjsurg.ca/60-3-192/
Pancreatic neuroendocrine tumors (pNETs) comprise with gastrointestinal carcinoids, the primary sets - Abl Family Kinases...Pancreatic neuroendocrine tumors (pNETs) comprise with gastrointestinal carcinoids, the primary sets - Abl Family Kinases...
Pancreatic neuroendocrine tumors (pNETs) comprise with gastrointestinal carcinoids, the primary sets of gastrointestinal neuroendocrine tumors (GI-NETs). menin (Desk-3). Menin interacts with several proteins/transcription elements, which are essential in regulating cell development, cell cycle development and several additional cellular procedures (Desk-3) [46]. Lately, furthermore to these traditional endocrine tumors, an elevated event of tumors in additional places are reported in Males1 individuals, including carcinoids (gastric, thymic, lung) [46,47]; CNS tumors (meningiomas, ependymomas) [46,48]; easy muscle mass tumors (leiomyomas and leiomyosarcomas) [46,49], and pores and skin tumors (angiofibromas, collagenomas, lipomas, melanomas) [46,50]. With regards to pNETs virtually all individuals with Males1 possess NF-PETs, yet, in most individuals they may be microscopic and therefore cause medical symptoms in mere 0C13% in various series (Desk-2) [46]. On the other hand, practical pNETs buy ...
http://movd2016.org/pancreatic-neuroendocrine-tumors-pnets-comprise-with-gastrointestinal-carcinoids-the-primary-sets/
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment...Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment...
This phase II trial is studying how well sorafenib works in treating patients with malignant gastrointestinal stromal tumor that progressed during or af
http://www.knowcancer.com/cancer-trials/NCT00265798/
Gallbladder Cancer - TAddona - Gallbladder Cancer Epidemiology • Incidence ~ 5000 • 5 th most common GI malignancy • Women| men...Gallbladder Cancer - TAddona - Gallbladder Cancer Epidemiology • Incidence ~ 5000 • 5 th most common GI malignancy • Women| men...
View Notes - Gallbladder Cancer - TAddona from STEP 1 at Montgomery College. Gallbladder Cancer Epidemiology • Incidence ~ 5000 • 5 th most common GI malignancy • Women > men • High
https://www.coursehero.com/file/6642434/Gallbladder-Cancer-TAddona/
Alternative Cancer Treatments for Gastrointestinal Carcinoid Cancer | New HopeAlternative Cancer Treatments for Gastrointestinal Carcinoid Cancer | New Hope
New Hope Unlimited offers personalized, non-invasive Alternative Cancer Treatments for Gastrointestinal Carcinoid Cancer. Call 480-666-1403 today.
https://www.newhopemedicalcenter.com/gastrointestinal-carcinoid-cancer/
Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets<...Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets<...
TY - JOUR. T1 - Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets. AU - King, PM. AU - Blazeby, JM. AU - Gupta, J. AU - Alderson, D. AU - Moorghen, M. PY - 2004/7. Y1 - 2004/7. N2 - Aims: Accurate pathological (pTNM) staging of oesophageal and gastric cancer provides important prognostic information. The aim of this study was to compare the standard of pathology reporting of oesophageal and gastric cancer resections from a cancer network with standards set by the Royal College of Pathologists. Methods: All reports for oesophageal and gastric cancer resections from the five hospitals in the cancer network in 2001 were collected. Individual items of information were compared with minimum datasets provided by the Royal College of Pathologists. Items were classified as complete, partially complete, or absent. Results: One hundred and ten reports were audited (54 oesophageal and 56 gastric). Fourteen gastric and 17 oesophagectomy ...
https://research-information.bris.ac.uk/en/publications/upper-gastrointestinal-cancer-pathology-reporting-a-regional-audi
Long-Term Aspirin Use Linked to Reduced Incidence of GI Cancers - MPRLong-Term Aspirin Use Linked to Reduced Incidence of GI Cancers - MPR
At the 25th UEG Week in Barcelona, researchers presented that long-term aspirin use significantly reduced the incidence of digestive cancers. The study c
http://www.empr.com/news/aspirin-cancer-gastrointestinal-liver-digestive-system/article/703980/
Basic trauma life support: knowledge of medical students :O Akiode, AA Musa, A Shonubi, FE Lesi, Nigerian Postgraduate Medical...Basic trauma life support: knowledge of medical students :O Akiode, AA Musa, A Shonubi, FE Lesi, Nigerian Postgraduate Medical...
BACKGROUND: The first hour of management (golden hour) of any trauma patient might be the determining factor if he/she will survive. The first contact most patients have in an emergency room is with a young medical graduate. The knowledge of basic trauma life support (BTLS) by all doctors therefore becomes important. AIMS AND OBJECTIVES: This study set out to assess how much knowledge medical students had about BTLS in their final year compared with their knowledge at the beginning of clinical postings. METHOD: A cross-sectional study of fourth and sixth (final) year medical students to evaluate their knowledge of BTLS using a test of 30 questions under examination conditions. One hundred and twenty-three fourth year students were given a test after a lecture on the care of injured patients. The same test was administered on 41 sixth year students without prior lecture on day of test, having had a similar lecture 2 years before. Data analysis was performed using the SPSS 11.0 for Windows ...
https://www.npmj.org/printarticle.asp?issn=1117-1936
Digestive Surgery Kolkata - GI Cancer | Obesity Surgery| BlogDigestive Surgery Kolkata - GI Cancer | Obesity Surgery| Blog
Get complete guidance on obesity, diabetes treatment, colon & GI problems from Digestive Surgery Clinic. Dr. Sarfaraz Baig will help you to be fit & health.
http://www.digestivesurgeryclinic.com/blog/
what are the different kinds of gi cancers? | Answers from Doctors | HealthTapwhat are the different kinds of gi cancers? | Answers from Doctors | HealthTap
Dr. Pavel Conovalciuc answered: Many: Oral cancer/pharyngeal/esophageal/stomach/pancreatic/liver/colon/rectal/endocrine cancers (usu...
https://www.healthtap.com/questions/13581-what-are-the-different-kinds-of-gi-cancers/
Immunology in GI cancer: What is useful and how to integrate it into the pathological report | OncologyPROImmunology in GI cancer: What is useful and how to integrate it into the pathological report | OncologyPRO
ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO or via grants from the sponsors and supporters.. Via L. Taddei 4, 6962 Viganello - Lugano - CH © Copyright 2017 European Society for Medical Oncology All rights reserved worldwide.. ...
http://oncologypro.esmo.org/Meeting-Resources/ESMO-2017-Congress/Immunology-in-GI-cancer-What-is-useful-and-how-to-integrate-it-into-the-pathological-report
Oncological management of gastro-entero-pancreatic neuroendocrine neoplasias | Klinikai OnkológiaOncological management of gastro-entero-pancreatic neuroendocrine neoplasias | Klinikai Onkológia
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are unusual and relatively rare neoplasms. They characteristically synthetize, store and secrete a variety of peptides and neuroamines, which can lead to development of disctinct clinical syndromes. Clinical symptoms and presentations vary depending on the location and hormones produced by the tumor. The diagnosis of NETs is established by histological examination and the immunohistochemical detection of general neuroendocrine markers, such as chromogranin A (CgA) and synaptophysin. An update of the WHO classifi cation has resulted in a new classification dividing neuroendocrine neoplasms into neuroendocrine tumors (NETs) including G1 (Ki67 index ≤2%) and G2 (Ki67 index 3-20%) tumors and neuroendocrine carcinomas (NECs) with Ki67 index ,20%, G3. The different available therapeutic approaches, including surgery, liver-directed ablative therapies, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, ...
http://klinikaionkologia.hu/oncological-management-of-gastro-entero-pancreatic-neuroendocrine-neoplasias/
Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines.
Gambogic acid has a marked anti-tumor effect for gastric and colorectal cancers in vitro and in vivo. However, recent investigations on gambogic acid have focused mainly on mono-drug therapy, and its potential role in cancer therapy has not been comp
http://www.biomedsearch.com/nih/Synergistic-anti-proliferative-effects-gambogic/22546220.html
Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer - Dülger - 2004 - International...Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer - Dülger - 2004 - International...
The aim was to investigate the serum levels of leptin, TNF-alpha, IL-1 beta, IL-6, insulin, and growth hormone in patients with upper gastrointestinal cancer and cachexia. A total of 39 patients with various advanced stage (stage IV) gastrointestinal malignancies were enrolled. These cancer patients were divided into two groups according to the presence or absence of cachexia. Fifteen healthy adults were recruited as the control group. Body mass index (BMI; kg/m2) was calculated. Serum leptin, tumour necrosis factor (TNF)-α interleukin (IL)-1 beta, interleukin (IL)-6, growth hormone, insulin, glucose, triglyceride, total protein, albumin, erythrocyte sedimentation rate, and CRP were measured. In both cancer groups (cachectic and non-cachectic) body mass index and serum leptin levels were lower than controls (p , 0.001). Serum IL-1 beta, IL-6, and growth hormone levels were higher in both cachectic and non-cachectic groups than those of controls (p , 0.05). Serum TNF-α level in non-cachectic ...
http://onlinelibrary.wiley.com/doi/10.1111/j.1368-5031.2004.00149.x/full?globalMessage=0
Keywords gastrointestinal + carcinoma | PEIR Digital Library
Welcome to the Pathology Education Informational Resource (PEIR) Digital Library, a multidisciplinary public access image database for use in medical education. ...
https://peir.path.uab.edu/library/index.php?/tags/3-gastrointestinal/112-carcinoma/start-30&display=large
ENETS Abstract library
Introduction: Sоmatostatin is a regulatory peptide with a variety of actions in normal and tumor cells. In recent years there are a lot of observations suggesting that the gastrointestinal neuroendocrine tumors (GEP-NETs) expressed somatostatin receptors (SS-R).The expression could be valuable for the prognosis of patients with GEP-NETs due to the research evidence that well-differentiated tumors express SS-R in the great majority of the cases ...
https://www.enets.org/abstract_library.html&search=Blot
Frameshift Somatic Mutations in Gastrointestinal Cancer of the Microsatellite Mutator Phenotype | Cancer ResearchFrameshift Somatic Mutations in Gastrointestinal Cancer of the Microsatellite Mutator Phenotype | Cancer Research
An exacerbated genomic instability characterizes hereditary and sporadic gastrointestinal cancer of the microsatellite mutator phenotype (MMP), generating somatic frameshift mutations in genes containing mononucleotide repeats. We have recently shown that approximately 50, 40, and 30% of MMP + colon tumors harbor frameshift mutations in (G)8, (A)8, and (C)8 tracks within the proapoptotic gene BAX and the hMSH3 and hMSH6 DNA mismatch repair genes, respectively. Here we report a higher incidence of frameshift mutations in these 3 genes in a panel of 25 MMP+ gastric adenocarcinomas: 64% in BAX and hMSH3, and 52% in hMSH6. These results support a multiple mutator gene model for the stepwise unfolding of the MMP and further illustrate the importance of the escape from apoptosis in gastrointestinal cancer. The tumor suppressor role played by BAX is also supported by the finding of other somatic BAX mutations, including recurrent missense mutations, not only in gastrointestinal cancer of the MMP but ...
https://cancerres.aacrjournals.org/content/57/19/4420?ijkey=efed9e42b67505df144c3ae530e4bd8f2867e226&keytype2=tf_ipsecsha
Community Academic Profiles - Faculty & Researchers - Stanford MedicineCommunity Academic Profiles - Faculty & Researchers - Stanford Medicine
Dr. Chin is committed to ensuring the delivery of care of the highest quality and value. He provides clinical expertise in diagnosing and treating the full range of cancers, including those of the lung, breast, and central nervous system. In addition, he serves on national leadership teams formed to advance the practice of cancer care. Dr. Chin is currently a member of the Payment Reform Task Force for the American Society of Clinical Oncology and has previously served on their Clinical Practice Committee and as a health policy fellow. He was one of just two oncologists in the US selected to participate in a year-long program on policy leadership ...
https://med.stanford.edu/profiles/pulmonary/browse?p=1&org=school-of-medicine/radiation-oncology&ps=20
Current status of gastrointestinal tract cancer brain metastasis and t by Yoshiaki Shoji, Satoru Furuhashi et al.Current status of gastrointestinal tract cancer brain metastasis and t by Yoshiaki Shoji, Satoru Furuhashi et al.
Brain metastasis (BM) frequently occurs in patients with cutaneous melanoma, lung, and breast cancer; although, BM rarely arises from cancers of the gastrointestinal tract (GIT). The reported incidence of GIT cancer BM is less than 4%. In the last few years, effective systemic therapy has prolonged the survival of GIT patients and consequently, the incidence of developing BM is rising. Therefore, the epidemiology and biology of BM arising from GIT cancer requires a more comprehensive understanding. In spite of the development of new therapeutic agents for patients with metastatic GIT cancers, survival for patients with BM still remains poor, with a median survival after diagnosis of less than 4 months. Limited evidence suggests that early detection of isolated intra-cranial lesions will enable surgical resection plus systemic and/or radiation therapy, which may lead to an increase in overall survival. Novel diagnostic methods such as blood-based biomarker biopsies may play a crucial role in the early
https://digitalcommons.psjhealth.org/publications/4845/
Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers | GutTumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers | Gut
Our goal was to assess the metastatic potential of CRC in order to develop clinically effective individualised treatment based on that potential against stage I of CRC (pT1N0M0). Using cDNA array, we first identified that of the many possible candidates, matrilysin was a major biomarker involved in nodal metastasis. We reported previously that matrilysin expression was confined to cancer cells, which not only correlated with tumour metastatic potential in a mouse model but was also implicated in the poor prognosis of gastrointestinal cancer patients. Moreover, matrilysin is an established target of the Wnt signal pathway. For these reasons, we specifically focused on matrilysin for further analysis.. MMPs have long been a potential target for cancer therapy. However, clinical trials of synthetic metalloproteinase inhibitors have been disappointing.26 One major reason for this lack of success may result from the apparent uncertainty regarding the precise spectrum of inhibitory activity required. ...
http://gut.bmj.com/content/54/12/1751
Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced...Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced...
This study aimed to investigate the efficacy and safety of cytokine-induced killer (CIK)/dendritic cell combined with CIK (DC-CIK) cell therapy in advanced gastrointestinal cancer (GIC). The PubMed, Cochrane library, and Embase were searched to conduct a meta-analysis of clinical controlled trials to evaluate the efficacy and safety of CIK/DC-CIK cell therapy in advanced GIC. The pooled risk ratios (RRs) or weighted mean difference (WMD) with 95% confidence intervals (95% CIs) were calculated. A total of nine studies with 1113 patients were identified. The overall survival (RR = 1.84, 95% CI = 1.41-2.40, Pheterogeneity = 0.654, I2 = 0%), progression-free survival (RR = 1.99, 95% CI = 1.52-2.60, Pheterogeneity = 0.727, I2 = 0%), and quality of life (WMD = 16.09, 95% CI = 1.66-30.52, Pheterogeneity | 0.001, I2 = 98.8%) were significantly improved in patients who received chemotherapy combined with CIK/DC-CIK cells, and no severe adverse events were reported. This meta-analysis suggested that the
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-06860-y/figures/5
Best Western Plus Universal Inn - Orlando, FL | GrouponBest Western Plus Universal Inn - Orlando, FL | Groupon
Fairfield Inn & Suites Orlando Near Universal Orlando Resort has the best amenities around. Enjoy Fairfield Inn & Suites Orlando Near Universal Orlando Resort when you stay in Orlando.Keep your expenses in check at Fairfield Inn & Suites Orlando Near Universal Orlando Resort, an establishment with affordable pricing. Worried about parking? Dont be. There are many parking facilities located within the area. So check in to Fairfield Inn & Suites Orlando Near Universal Orlando Resort for a great nights rest while youre on Orlando.
https://www.groupon.com/biz/orlando/fairfield-inn-suites-orlando-near-universal-orlando-resort
Gastrointestinal cancer - WikipediaGastrointestinal cancer - Wikipedia
Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract (GI tract) and accessory organs of digestion, including the esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum and anus. The symptoms relate to the organ affected and can include obstruction (leading to difficulty swallowing or defecating), abnormal bleeding or other associated problems. The diagnosis often requires endoscopy, followed by biopsy of suspicious tissue. The treatment depends on the location of the tumor, as well as the type of cancer cell and whether it has invaded other tissues or spread elsewhere. These factors also determine the prognosis. Overall, the GI tract and the accessory organs of digestion (pancreas, liver, gall bladder) are responsible for more cancers and more deaths from cancer than any other system in the body. There is significant geographic variation in the rates of different gastrointestinal cancers. Esophageal cancer is the sixth-most-common ...
https://en.wikipedia.org/wiki/Gastrointestinal_cancer
Lymphoma Archives - Cancer TutorLymphoma Archives - Cancer Tutor
Common cancers Bladder Cancer Breast Cancer Colorectal Cancer Head and Neck Cancer Kidney Cancer Lung Cancer Lymphoma Melanoma Pancreatic Cancer Prostate Cancer Thyroid Cancer Uterine Cancer AAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)AdenocarcinomaAdrenocortical CarcinomaAIDS-Related LymphomaAnal CancerAppendix Cancer - see Gastrointestinal Carcinoid Tumors BBasal Cell Carcinoma - see Skin Cancer (Nonmelanoma)Bile Duct Cancer, ExtrahepaticBladder CancerBone Cancer […]. ...
https://www.cancertutor.com/topics/lymphoma/
small intestinal hodgkins lymphoma drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J, Temmesfeld A, Schmitz R, Rübe C, Probst A, Jaenke G, Bodenstein H, Junker A, Pott C, Schultze J, Heinecke A, Parwaresch R, Tiemann M, German Multicenter Study Group: Primary gastrointestinal non-Hodgkins lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol; 2001 Sep 15;19(18):3861-73 ...
http://www.bmlsearch.com/?kwr=small+intestinal+hodgkin
Jill Lacy | Specialists | Yale MedicineJill Lacy | Specialists | Yale Medicine
Dr. Jill Lacy is Professor of Medicine in the Section of Medical Oncology at Yale School of Medicine with over 30 years of experience as a practicing Medical Oncologist. Dr. Lacy graduated from Yale School of Medicine in 1978, completed training in Internal Medicine and Medical Oncology at Yale, and is board-certified in Internal Medicine and Medical Oncology. Dr. Lacys early career was focused on clinical and basic research related to Epstein Barr virus-mediated oncogenesis and HIV-associated malignancies during the height of the AIDS epidemic. In recent years, Dr. Lacys clinical practice has been devoted to caring for patients with gastrointestinal malignancies. Her current research is focused on therapeutic clinical trials in GI malignancies, including gastroesophageal, pancreatic, and colorectal cancers. She is the principle investigator on a number of investigator-initiated, pharmaceutical, and cooperative group studies. She has served on national committees focused on optimizing the education
https://www.yalemedicine.org/specialists/jill_lacy
Are patients with pediatric Crohn disease at increased risk for developing GI malignancies?Are patients with pediatric Crohn disease at increased risk for developing GI malignancies?
Colonic malignancy is a clinically significant complication of Crohn disease in patients with pancolitis beginning in childhood. Although the risk of malignancy in Crohn disease is not as high as that... more
https://www.medscape.com/answers/928288-180323/are-patients-with-pediatric-crohn-disease-at-increased-risk-for-developing-gi-malignancies
Honorary Lecture: Developmental pathways altered in GI malignancies | OncologyPROHonorary Lecture: Developmental pathways altered in GI malignancies | OncologyPRO
ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO or via grants from the sponsors and supporters.. Via L. Taddei 4, 6962 Viganello - Lugano - CH © Copyright 2017 European Society for Medical Oncology All rights reserved worldwide.. ...
http://oncologypro.esmo.org/Topics/Gastrointestinal-Cancers/Honorary-Lecture-Developmental-pathways-altered-in-GI-malignancies
Gastrointestinal lymphoma: the new mimic | BMJ Open GastroenterologyGastrointestinal lymphoma: the new mimic | BMJ Open Gastroenterology
Various strategies and modalities of treatment are employed in the management of GI lymphomas based on the area of involvement, histological type and clinical staging.12 39 40 For example, early-stage follicular lymphoma follows an indolent course and may be followed clinically with a watch and wait policy.41 Indeed, a retrospective study by Young and colleagues noted a similar overall 7.5-year survival rate among those with follicular lymphoma that underwent watchful waiting or aggressive combined modality treatment.42. More than 70% of patients with early-stage (Ann Arbor Classification Stages I-III) MALT lymphomas associated with H. pylori infection can achieve remission with triple or quadruple eradication therapy alone,4 43 44 with a tumour location, patient ethnicity, depth of invasion and molecular feature all influencing response rates.24 Radiation therapy and chemotherapy are reserved for advanced tumours and non-responders. Surgery should prove necessary only in instances of ...
https://bmjopengastro.bmj.com/content/6/1/e000320
https://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdqhttps://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq
Gastrointestinal carcinoid tumor treatment often includes resection of the primary tumor and local lymph nodes. Other treatment options include somatostatin analogs, interferons, treatment of hepatic masses, radionuclides, and symptomatic therapy. Get detailed information in this clinician summary.
https://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq
Decision Making in Feline Cancer Patients - WSAVA2008 - VINDecision Making in Feline Cancer Patients - WSAVA2008 - VIN
Introduction. This short presentation will describe approaches to these diseases, standard treatment protocols and advances in radiation and chemotherapy-based treatments. Particular emphasis will be placed upon the special considerations in cats with regards drug metabolism, nutritional support during therapy and prognosis of individual diseases.. Feline Lymphoma. Diagnosis and Staging. The various anatomical forms of feline lymphoma (mediastinal, alimentary, renal, multicentric and extranodal) have been well described. Alimentary--characterised by gastric, intestinal, or mesenteric lymph node involvement, this is one of the more common forms of feline lymphoma. Gastrointestinal lymphoma may present as a solitary mass lesion or as a diffuse infiltration of extensive areas of bowel. Clinical signs are non-specific, including anorexia, vomiting, and diarrhoea. Animals previously diagnosed with lymphoplasmacytic gastroenteritis have been reported subsequently to develop gastrointestinal lymphoma. ...
http://www.vin.com/apputil/content/defaultadv1.aspx?pId=11268&id=3866631
Guide to managing persistent upper gastrointestinal symptoms during and after treatment for cancer | Frontline GastroenterologyGuide to managing persistent upper gastrointestinal symptoms during and after treatment for cancer | Frontline Gastroenterology
This guide is designed for all clinicians who look after people who have been treated for upper gastrointestinal (GI) cancer. It is also designed for patients who are experiencing upper GI symptoms following any cancer treatment. Some of these will be doctors, others may be senior nurses and increasingly, other allied health professionals.. Some lower GI symptoms are also included because these are common after treatment for upper GI cancers. However, for more detailed advice about managing lower GI symptoms please refer to Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease.1. The GI consequences of chemotherapy, radiotherapy and resectional surgery are not that different. Historically, clinicians have associated specific clusters of symptoms with typical diagnoses especially in patients who have been treated for upper GI and hepatopancreatobiliary cancer. Research increasingly suggests that specific symptoms are not reliable indicators of the ...
http://fg.bmj.com/content/8/4/295
Gastrointestinal Stents Market To Reach Worth US$ 510 Mn By 2025 - Credence Research | MCTGastrointestinal Stents Market To Reach Worth US$ 510 Mn By 2025 - Credence Research | MCT
According to the latest report published by Credence Research, Inc. Gastrointestinal Stents Market - Growth, Future Prospects and Competitive Analysis, 2017-2025, the global gastrointestinal stents market was valued at US$ 348.9 Mn in 2016, and is expected to reach US$ 510.0 Mn by 2025, expanding at a CAGR of 4.2% from 2017 to 2025.. Browse the full report Gastrointestinal Stents Market - Growth, Future Prospects and Competitive Analysis, 2017-2025 at http://www.credenceresearch.com/report/gastrointestinal-stents-market. Market Insights Gastrointestinal diseases are highly prevalent in high risk geriatric population. Drastic change in lifestyle and dietary habits has resulted in rise in prevalence of chronic diseases, obesity, high blood pressure, and also has resulted in escalated morbidity and mortality from conditions such as GI cancers, bowel diseases, and others. Gastrointestinal stents are used for correcting obstructions in the GI tract and in cases of strictures, tumors, and ...
http://www.mobilecomputingtoday.co.uk/6066/gastrointestinal-stents-market-reach-worth-510-2025-credence-research/
Funding Opportunities - Vanderbilt-Ingram Cancer CenterFunding Opportunities - Vanderbilt-Ingram Cancer Center
The Breast SPORE Developmental Research Program provides pilot funding to promote excellent translational research in breast cancer. These funds allow early, high-risk research to move solid basic science findings toward clinical application, as well as the migration of provocative clinical observations back to the laboratory in order to understand their mechanistic basis. Main criteria for selection and funding of developmental (pilot) projects include scientific merit, relevance to mammary biology and/or breast cancer, collaboration and potential for extramural peer-reviewed funding. There also is an emphasis on utilization of emerging technologies and on young investigators.. The GI SPORE Developmental Research Program solicits applications twice yearly from investigators at Vanderbilt and Meharry Medical College. Proposals are reviewed for scientific merit and the likelihood of leading to extramural funding. Special emphasis is placed on attracting young investigators into GI cancer ...
http://www.vicc.org/research/funding/
Aspirin May Double the Survival Rates for Cancer Patients, Says StudyAspirin May Double the Survival Rates for Cancer Patients, Says Study
A new study presented at the 2015 European Cancer Congress in Vienna, Austria suggests that aspirin may double the chances of survival for people with gastrointestinal (GI) cancers.
https://www.doctorshealthpress.com/health-news/aspirin-may-double-survival-rates-for-cancer-patients/
Pancreatic mucinous cystic neoplasmPancreatic mucinous cystic neoplasm
Gastrointestinal Endoscopy. 67 (4): 636-42. doi:10.1016/j.gie.2007.09.038. PMID 18262182. Oh, HC; Seo, DW; Song, TJ; Moon, SH; ... Pancreatic mucinous cystic neoplasm (MCN) is a type of cystic lesion that occurs in the pancreas. Amongst individuals ... Intraductal papillary mucinous neoplasm Pancreatic serous cystadenoma Elta, GH; Enestvedt, BK; Sauer, BG; Lennon, AM (April ... Where possible, surgical resection of mucinous cystic neoplasms is preferable. In individuals who are eligible to undergo ...
https://en.wikipedia.org/wiki/Pancreatic_mucinous_cystic_neoplasm
Intraductal papillary mucinous neoplasmIntraductal papillary mucinous neoplasm
World Journal of Gastrointestinal Surgery. 2 (10): 342-6. doi:10.4240/wjgs.v2.i10.342. ISSN 1948-9366. PMC 2999210. PMID ... Pancreatic serous cystadenoma Solid pseudopapillary neoplasm "Intraductal Papillary Mucinous Neoplasms of the Pancreas". Johns ... Intraductal papillary mucinous neoplasm (IPMN) is a type of tumor that can occur within the cells of the pancreatic duct. IPMN ... Campbell, NM; Katz, SS; Escalon, JG; Do, RK (March 2015). "Imaging patterns of intraductal papillary mucinous neoplasms of the ...
https://en.wikipedia.org/wiki/Intraductal_papillary_mucinous_neoplasm
Endoscopic submucosal dissectionEndoscopic submucosal dissection
Application of endoscopic resection (ER) to gastrointestinal (GI) neoplasms is limited to lesions with no risk of nodal ... The resected size and shape can be controlled, en bloc resection is possible even in a large neoplasm, and neoplasms with ... Kakushima, Naomi; Fujishiro, Mitsuhiro (2008). "Endoscopic submucosal dissection for gastrointestinal neoplasms". World Journal ... So this technique can be applied to the resection of complex neoplasms such as large neoplasms, ulcerative non-lifting ...
https://en.wikipedia.org/wiki/Endoscopic_submucosal_dissection
Anaerobic infectionAnaerobic infection
... recent gastrointestinal, obstetric, or gynecologic surgery; malignant neoplasms intestinal obstruction; decubitus ulcers; ... colonize the lower gastrointestinal tract, they can contaminate compound lower extremities fractures.[citation needed] Septic ... is often associated with a gastrointestinal source, pigmented Prevotella and Porphyromonas spp. and Fusobacterium spp.with ... Perforated appendicitis, diverticulitis, inflammatory bowel disease with perforation and gastrointestinal surgery are often ...
https://en.wikipedia.org/wiki/Anaerobic_infection
NeoplasmNeoplasm
Bernstein C, Bernstein H, Payne CM, Dvorak K, Garewal H (February 2008). "Field defects in progression to gastrointestinal ... ICD-10 classifies neoplasms into four main groups: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of ... The term neoplasm is a synonym of tumor. Neoplasia denotes the process of the formation of neoplasms/tumors, and the process is ... The process that occurs to form or produce a neoplasm is called neoplasia. The growth of a neoplasm is uncoordinated with that ...
https://en.wikipedia.org/wiki/Neoplasm
Indolent T cell lymphoproliferative disorder of the gastrointestinal tractIndolent T cell lymphoproliferative disorder of the gastrointestinal tract
Matutes E (May 2018). "The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms". International Journal of ... Indolent T cell lymphoproliferative disorder of the gastrointestinal tract or Indolent T cell lymphoproliferative disorder of ... Weindorf SC, Smith LB, Owens SR (November 2018). "Update on Gastrointestinal Lymphomas". Archives of Pathology & Laboratory ... Cahu X, Constantinescu SN (December 2015). "Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin ...
https://en.wikipedia.org/wiki/Indolent_T_cell_lymphoproliferative_disorder_of_the_gastrointestinal_tract
Neuroendocrine tumorNeuroendocrine tumor
G1 and G2 neuroendocrine neoplasms are called neuroendocrine tumors (NETs) - formerly called carcinoid tumours. G3 neoplasms ... Most gastrointestinal carcinoid tumors tend not to respond to chemotherapy agents, showing 10 to 20% response rates that are ... Although there are many kinds of NETs, they are treated as a group of tissue because the cells of these neoplasms share common ... Gastrointestinal Carcinoid Tumors Treatment cancer.gov Archived 2011-06-27 at the Wayback Machine National Cancer Institute. ...
https://en.wikipedia.org/wiki/Neuroendocrine_tumor
AnthramycinAnthramycin
... has been shown particularly effective against sarcomas, lymphomas, and gastrointestinal neoplasms.[citation needed ...
https://en.wikipedia.org/wiki/Anthramycin
Small intestine cancerSmall intestine cancer
It is relatively rare compared to other gastrointestinal malignancies such as gastric cancer (stomach cancer) and colorectal ... Malignant Neoplasms of the Small Intestine. eMedicine.com. URL: http://www.emedicine.com/MED/topic2651.htm. Accessed on: June 2 ... Five-year survival rates are 65%. Subtypes of small intestine cancer include: Adenocarcinoma Gastrointestinal stromal tumor ... Articles with short description, Short description is different from Wikidata, Gastrointestinal cancer). ...
https://en.wikipedia.org/wiki/Small_intestine_cancer
Gastrointestinal stromal tumorGastrointestinal stromal tumor
... s (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. GISTs arise in ... many non-epithelial tumors of the gastrointestinal tract were called "gastrointestinal stromal tumors". Histopathologists were ... KIT-p.D419del (exon 8) - A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic ... GISTs are tumors of connective tissue, i.e. sarcomas; unlike most gastrointestinal tumors, they are nonepithelial. About 70% ...
https://en.wikipedia.org/wiki/Gastrointestinal_stromal_tumor
MLH1MLH1
"Clinicopathological relevance of the association between gastrointestinal and sebaceous neoplasms: the Muir-Torre syndrome". ... Bernstein C, Bernstein H (2015). "Epigenetic reduction of DNA repair in progression to gastrointestinal cancer". World J ...
https://en.wikipedia.org/wiki/MLH1
Pancreatic serous cystadenomaPancreatic serous cystadenoma
... mixed serous-endocrine neoplasm, and VHL-associated serous cystic neoplasm. This latter classification scheme is useful because ... Journal of Gastrointestinal Surgery. 11 (7): 820-826. doi:10.1007/s11605-007-0157-4. PMID 17440789. S2CID 32023143. Elta GH, ... Serous cystic neoplasms that have spread ("metastasized") to another organ are considered malignant and are designated "serous ... In contrast to some of the other cyst-forming tumors of the pancreas (such as the intraductal papillary mucinous neoplasm and ...
https://en.wikipedia.org/wiki/Pancreatic_serous_cystadenoma
Muir-Torre syndromeMuir-Torre syndrome
Along with neoplasms of the sebaceous gland, this patient developed cerebral neoplasms, characteristic of Turcot syndrome. ... Gastrointestinal and genitourinary cancers are the most common internal malignancies. Colorectal cancer is the most common ... Age of onset of first sebaceous neoplasm: 2 = 2 points. Personal history of Lynch related cancers: No = 0 points, Yes = 1 point ... 2014). "A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch ...
https://en.wikipedia.org/wiki/Muir–Torre_syndrome
Human fecesHuman feces
... ulcerative colitis and neoplasms (cancer). Also, feces may be analyzed for any fecal occult blood, which is indicative of a ... combines with gastrointestinal bleeding from any source (black stool). It can also suggest a carcinoma of the ampulla of Vater ... which will result in gastrointestinal bleeding and biliary obstruction, resulting in silver stool. Feces can be green due to ... gastrointestinal bleeding. A quick test for fecal contamination of water sources or soil is a check for the presence of E. coli ...
https://en.wikipedia.org/wiki/Human_feces
Retroperitoneal spaceRetroperitoneal space
The most common type is a sarcoma followed by lymphoma, extragonadal germ cell tumor, and Gastrointestinal stromal tumor/GIST. ... Retroperitoneal fibrosis Retroperitoneal lymph node dissection It is also possible to have a neoplasm in this area, more ... commonly a metastasis; or very rarely a primary neoplasm. ...
https://en.wikipedia.org/wiki/Retroperitoneal_space
MedDRAMedDRA
Neoplasms benign, malignant and unspecified (incl cysts and polyps); Nervous system disorders; Pregnancy, puerperium and ... Gastrointestinal disorders; General disorders and administration site conditions; Hepatobiliary disorders; Immune system ...
https://en.wikipedia.org/wiki/MedDRA
Siamese catSiamese cat
The majority of deaths were caused by neoplasms, mainly mammary tumors. The Siamese also has a higher rate of morbidity. They ... are at higher risk of neoplastic and gastrointestinal problems, but have a lower risk of feline lower urinary tract disease. ...
https://en.wikipedia.org/wiki/Siamese_cat
ToxicodynamicsToxicodynamics
Neoplasms occurring in epithelial tissue such as the liver, gastrointestinal tract, and the pancreas have been linked to ...
https://en.wikipedia.org/wiki/Toxicodynamics
Attenuated familial adenomatous polyposisAttenuated familial adenomatous polyposis
Gastrointestinal cancer, Hereditary cancers, All stub articles, Neoplasm stubs). ...
https://en.wikipedia.org/wiki/Attenuated_familial_adenomatous_polyposis
HamartomaHamartoma
When seen on upper gastrointestinal series, a pancreatic rest may appear to be a submucosal mass or gastric neoplasm. Most are ... A hamartoma is a mostly benign, local malformation of cells that resembles a neoplasm of local tissue but is usually due to an ... Case report: ectopic pancreatic rest in the proximal stomach mimicking gastric neoplasms. Clin Radiol. 2007 Jun;62(6):600-2. ... the definition of hamartoma versus benign neoplasm is often unclear, since both lesions can be clonal. Lesions such as adenomas ...
https://en.wikipedia.org/wiki/Hamartoma
David B. AdamsDavid B. Adams
... , M.D. (born 1950) is Professor of Surgery, Chief, Division of Gastrointestinal and Laparoscopic Surgery and Co- ... Ellis, C. T.; Barbour, J. R.; Shary, T. M.; Adams, D. B. (2010). "Pancreatic cyst: Pseudocyst or neoplasm? Pitfalls in ... Theruvath, T. P.; Morgan, K. A.; Adams, D. B. (2010). "Mucinous cystic neoplasms of the pancreas: How much preoperative ... Association American College of Surgeons American Society for Gastrointestinal Endoscopy Society of American Gastrointestinal ...
https://en.wikipedia.org/wiki/David_B._Adams
Large intestineLarge intestine
The gastrointestinal tract is derived from these layers. One variation on the normal anatomy of the colon occurs when extra ... and left-sided colorectal neoplasms after colonoscopy: population-based study". J Natl Cancer Inst. 102 (2): 89-95. doi:10.1093 ... The large intestine, also known as the large bowel, is the last part of the gastrointestinal tract and of the digestive system ... The descending colon is also called the distal gut, as it is further along the gastrointestinal tract than the proximal gut. ...
https://en.wikipedia.org/wiki/Large_intestine
Tyrosine kinaseTyrosine kinase
Gastrointestinal stromal tumors consist of a cluster of mesenchymal neoplasms that are formed from precursors to cells that ... Gastrointestinal stromal tumors (GIST) are mesenchymal tumors that affect the gastrointestinal tract. Treatment options have ... Therapy with imatinib can inhibit the non-normal cell signaling mechanisms in gastrointestinal stromal tumors. This results in ... There are no effective means of treatment for advanced gastrointestinal stromal tumors, but that STI571 represents an effective ...
https://en.wikipedia.org/wiki/Tyrosine_kinase
Carneys triadCarney's triad
Carney triad (CT) is characterized by the coexistence of three types of neoplasms, mainly in young women, including gastric ... A third condition, the Carney-Stratakis syndrome (CSS), describes the dyad of hereditary gastrointestinal stromal tumor (GIST) ... The Carney complex is a distinct entity, characterized by myxomatous neoplasms (cardiac, endocrine, cutaneous and neural), and ... Subsequent advances in molecular biology have led to the current terminology of gastrointestinal stromal tumors (GISTs). ...
https://en.wikipedia.org/wiki/Carney's_triad
Mesoblastic nephromaMesoblastic nephroma
... of all childhood renal neoplasms. This neoplasm is generally non-aggressive and amenable to surgical removal. However, a ... 2 with gastrointestinal anomalies, 1 with hydrocephalus, and 1 with the Beckwith-Wiedemann syndrome. The vast majority of ... It shows a mixture of the classic and cellular types in different areas of the neoplasm. A study conducted in 1998 found that ... Congenital mesoblastic nephroma, while rare, is the most common kidney neoplasm diagnosed in the first three months of life and ...
https://en.wikipedia.org/wiki/Mesoblastic_nephroma
Intraepithelial neoplasiaIntraepithelial neoplasia
Hackeng WM, Hruban RH, Offerhaus GJ, Brosens LA (2016). "Surgical and molecular pathology of pancreatic neoplasms". Diagn ... 2000). "The Vienna classification of gastrointestinal epithelial neoplasia". Gut. 47 (2): 251-5. doi:10.1136/gut.47.2.251. PMC ...
https://en.wikipedia.org/wiki/Intraepithelial_neoplasia
MALT lymphomaMALT lymphoma
2012). Handbook of Gastrointestinal Cancer (2 ed.). Chicester: John Wiley and Sons Ltd. pp. 243-244. ISBN 978-0-470-65624-2. ... ISBN 0-7817-5007-5. Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and ... Gastrointestinal cancer, Lymphoma, Infectious causes of cancer). ...
https://en.wikipedia.org/wiki/MALT_lymphoma
Neurofibromin 1Neurofibromin 1
... gastrointestinal stromal tumors (GIST), Watson syndrome, astrocytic neoplasms, phaeochromocytomas and breast cancer. No ... which develops myeloproliferative neoplasms similar to those found in NF1 juvenile myelomonocytic leukemia/JMML) were used to ... an oral selective MEK inhibitor used previously in several advanced adult neoplasms. The children enrolled in the study ...
https://en.wikipedia.org/wiki/Neurofibromin_1
EndoscopeEndoscope
Edmonson JM (March 1991). "History of the instruments for gastrointestinal endoscopy". Gastrointestinal Endoscopy. 37 (2 Suppl ... Small intestine: small intestine neoplasms, smooth muscle tumors, sarcomas, polyps, lymphomas, inflammation, etc. Large ... Whilst there are regions of the body that will always require flexible endoscopes (principally the gastrointestinal tract), the ... Health care workers can use endoscopes to review the following body parts: The gastrointestinal tract: Esophagus: chronic ...
https://en.wikipedia.org/wiki/Endoscope
Pseudomyxoma peritoneiPseudomyxoma peritonei
For example, neoplasms characterized by high-grade features, invasive glands and or signet ring cells, are termed ... Harmon RL, Sugarbaker PH (February 2005). "Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer". ... Young RH (May 2004). "Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms". Seminars in ... ISBN 978-0-323-35909-2. Sugarbaker PH (January 2006). "New standard of care for appendiceal epithelial neoplasms and ...
https://en.wikipedia.org/wiki/Pseudomyxoma_peritonei
Appendix cancerAppendix cancer
Gastrointestinal stromal tumors are rare tumors with malignant potential. Primary lymphomas can occur in the appendix. Breast ... Mucinous cystadenoma is an obsolete term for appendiceal mucinous neoplasm. Small carcinoids (. ...
https://en.wikipedia.org/wiki/Appendix_cancer
List of diseases (C)List of diseases (C)
Carrington syndrome Cartilage hair hypoplasia like syndrome Cartilage-hair hypoplasia Cartilaginous neoplasms Cartwright-Nelson ... Congenital erythropoietic porphyria Congenital facial diplegia Congenital fiber type disproportion Congenital gastrointestinal ... hypoxia Cerebral malformations hypertrichosis claw hands Cerebral palsy Cerebral thrombosis Cerebral ventricle neoplasms ... Choriocarcinoma Chorioretinitis Chorioretinopathy dominant form microcephaly Choroid plexus cyst Choroid plexus neoplasms ...
https://en.wikipedia.org/wiki/List_of_diseases_(C)
Index of biochemistry articlesIndex of biochemistry articles
... neoplasm protein - Nernst equation - nerve - nerve growth factor - nerve growth factor receptor - nerve tissue protein - nerve ... gastrointestinal hormone receptor - gastrula - gel electrophoresis - gene - gene expression - gene pool - gene regulatory ...
https://en.wikipedia.org/wiki/Index_of_biochemistry_articles
Primary effusion lymphomaPrimary effusion lymphoma
Gastrointestinal track lesions often occur as multiple lymphoid polyps in the large intestine. At diagnosis, more than 50% of ... This lymphoma also belongs to a group of lymphoid neoplasms with plasmablastic differentiation that involve malignant ... The extracavitary tumors may develop in lymph nodes, bone, bone marrow, the gastrointestinal tract, skin, spleen, liver, lungs ... Individuals with extracavitary PEL present with lesions in the lung, central nervous system, gastrointestinal tract, and/or ...
https://en.wikipedia.org/wiki/Primary_effusion_lymphoma
Dendritic cellDendritic cell
Blastic plasmacytoid dendritic cell neoplasm is a rare type of myeloid cancer in which malignant pDCs infiltrate the skin, bone ... gastrointestinal tract, bone, sinuses, ears, and/or testes. The disease may also present as a pDC leukemia, i.e. increased ... Wang S, Wang X, Liu M, Bai O (April 2018). "Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel ... Blastic plasmacytoid dendritic cell neoplasm has a high rate of recurrence following initial treatments with various ...
https://en.wikipedia.org/wiki/Dendritic_cell
Low-grade myofibroblastic sarcomaLow-grade myofibroblastic sarcoma
Baranov E, Hornick JL (March 2020). "Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck ... the thin layer of tissue lying just below the mucous membranes that line passageways such as the gastrointestinal, respiratory ...
https://en.wikipedia.org/wiki/Low-grade_myofibroblastic_sarcoma
Rectal dischargeRectal discharge
Rare neoplasms at this site that can give rise to discharge include Paget's disease (which is possibly a type of adenocarcinoma ... Vernava AM, Moore BA, Longo WE, Johnson FE (1997). "Lower gastrointestinal bleeding". Dis. Colon Rectum. 40 (7): 846-58. doi: ...
https://en.wikipedia.org/wiki/Rectal_discharge
CancerCancer
They form a subset of neoplasms. A neoplasm or tumor is a group of cells that have undergone unregulated growth and will often ... Rates of gastrointestinal cancers are increased in people with Crohn's disease and ulcerative colitis, due to chronic ... In the general population, NSAIDs reduce the risk of colorectal cancer; however, due to cardiovascular and gastrointestinal ... World Journal of Gastrointestinal Oncology. 5 (3): 43-49. doi:10.4251/wjgo.v5.i3.43. PMC 3648662. PMID 23671730. Narayanan L, ...
https://en.wikipedia.org/wiki/Cancer
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Gastrointestinal (GI) involvement can rarely occur with chronic lymphocytic leukemia. Some of the reported manifestations ... Hairy cell leukemia is also a neoplasm of B lymphocytes, but the neoplastic cells have a distinct morphology under the ... ISBN 978-0-7817-5007-3. Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and ... Choi SM, O'Malley DP (December 2018). "Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms". ...
https://en.wikipedia.org/wiki/Chronic_lymphocytic_leukemia
Adrenal medullaAdrenal medulla
Neoplasms include: Pheochromocytoma (most common), a catecholamine-secreting tumor of the adrenal medulla Neuroblastoma, a ... blood vessel constriction in the skin and gastrointestinal tract, smooth muscle (bronchiole and capillary) dilation, and ...
https://en.wikipedia.org/wiki/Adrenal_medulla
Periodontal diseasePeriodontal disease
... diarrhoea and gastrointestinal disturbances. There is currently low-quality evidence suggesting if adjunctive systemic ... induced Genetic/developmental disorders Specific infections Inflammatory and immune conditions Reactive processes Neoplasms ...
https://en.wikipedia.org/wiki/Periodontal_disease
PhenoxybenzaminePhenoxybenzamine
Due to its 5-HT2A receptor antagonism, phenoxybenzamine is useful in the treatment of carcinoid tumor, a neoplasm that secretes ... 206-. ISBN 978-0-08-054111-2. Timothy S. Gaginella; James J. Galligan (25 July 1995). Serotonin and Gastrointestinal Function. ...
https://en.wikipedia.org/wiki/Phenoxybenzamine
Radiation therapyRadiation therapy
Radiation enteropathy The gastrointestinal tract can be damaged following abdominal and pelvic radiotherapy. Atrophy, fibrosis ... Hypopituitarism commonly develops after radiation therapy for sellar and parasellar neoplasms, extrasellar brain tumours, head ...
https://en.wikipedia.org/wiki/Radiation_therapy
Lower gastrointestinal bleedingLower gastrointestinal bleeding
H7 Shigella Salmonella Campylobacter jejuni Hemorrhoids Neoplasm - such as colorectal cancer Angiodysplasia Bleeding from a ... Lower gastrointestinal bleeding, commonly abbreviated LGIB, is any form of gastrointestinal bleeding in the lower ... LGIB accounts for 30-40% of all gastrointestinal bleeding and is less common than upper gastrointestinal bleeding (UGIB). It is ... A lower gastrointestinal bleed is defined as bleeding originating distal to the ileocecal valve which includes the colon, ...
https://en.wikipedia.org/wiki/Lower_gastrointestinal_bleeding
List of skin conditionsList of skin conditions
... neoplasms, and cysts are skin lesions that develop from the epidermal layer of the skin. Aberrant basal cell carcinoma ... "Paraneoplastic dermatological manifestation of gastrointestinal malignancies". World J. Gastroenterol. 15 (35): 4372-79. doi: ... an overview with emphasis on the myeloid neoplasms". Chem. Biol. Interact. 184 (1-2): 16-20. doi:10.1016/j.cbi.2009.10.009. ... neoplasms invading or aberrantly present in the dermis. Acquired progressive lymphangioma (benign lymphangioendothelioma) Acral ...
https://en.wikipedia.org/wiki/List_of_skin_conditions
Plasmacytoid dendritic cellPlasmacytoid dendritic cell
Wang S, Wang X, Liu M, Bai O (April 2018). "Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel ... gastrointestinal tract, bone, sinuses, ears, and/or testes. The disease may also present as a pDC leukemia, i.e. increased ... Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare type of myeloid cancer in which malignant pDCs infiltrate the ... pDCs that undergo malignant transformation cause a rare hematologic disorder, blastic plasmacytoid dendritic cell neoplasm. In ...
https://en.wikipedia.org/wiki/Plasmacytoid_dendritic_cell
MalignancyMalignancy
This includes bone marrow suppression, gastrointestinal problems and alopecia. Some side effects are specific to the anticancer ... Uses of "malignant" in oncology include: Malignancy, malignant neoplasm and malignant tumor are synonymous with cancer ...
https://en.wikipedia.org/wiki/Malignancy
Nicolaus Copernicus University Ludwik Rydygier Collegium Medicum in BydgoszczNicolaus Copernicus University Ludwik Rydygier Collegium Medicum in Bydgoszcz
In the 2000s, scientific research conducted by the institution focused on various domains: neoplasm, injury and their ... Surgery Department of Urology and Andrology Cell and Tissue Bank Laboratory for Pediatric Endoscopy and Gastrointestinal ... Neoplasms and Tuberculosis Department of Infectious Diseases and Hepatology Department of Dermatology and Venereology ...
https://en.wikipedia.org/wiki/Nicolaus_Copernicus_University_Ludwik_Rydygier_Collegium_Medicum_in_Bydgoszcz
Iodine-131Iodine-131
It can also cause sialadenitis (an inflammation of the salivary gland), gastrointestinal disturbances, allergic reactions and ... "Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative ...
https://en.wikipedia.org/wiki/Iodine-131
Ollier diseaseOllier disease
While chondrosarcoma is the most common form of a secondary malignant bone neoplasm found in cases of Ollier disease, other ... like chondrosarcomas but also much more aggressive tumors such as acute lymphocytic leukemia and gastrointestinal and ovarian ... Early detection and consistent and repeated monitoring is important in order to prevent and treat any potential bone neoplasms ... Clinical and radiological evaluations are conducted in order to detect the presence of bone neoplasms or lesions typically ...
https://en.wikipedia.org/wiki/Ollier_disease
Brain metastasisBrain metastasis
Neoplasm Metastasis Cancer Brain tumor Tse V (10 November 2009). "Brain Metastasis". Medscape. Retrieved 13 January 2010. " ... Gastrointestinal cancers, especially colorectal and pancreatic carcinoma, 3% Lymphoma, 1% Lung cancer and melanoma are most ... Percy AK, Elveback LR, Okazaki H, Kurland LT (January 1972). "Neoplasms of the central nervous system. Epidemiologic ... the national survey of intracranial neoplasms". Neurology. 35 (2): 219-26. doi:10.1212/WNL.35.2.219. PMID 3969210. S2CID ...
https://en.wikipedia.org/wiki/Brain_metastasis
Tumors of the hematopoietic and lymphoid tissuesTumors of the hematopoietic and lymphoid tissues
CEBPA mutation Myeloid neoplasms with germline DDX41 mutation Myeloid neoplasms with germline RUNX1 mutation Myeloid neoplasms ... NOS Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract Hepatosplenic T-cell lymphoma Subcutaneous ... neoplasms with PDGFRA rearrangement Myeloid/lymphoid neoplasms with PDGFRB rearrangement Myeloid/lymphoid neoplasms with FGFR1 ... NOS Lymphoid neoplasms Precursor lymphoid neoplasms B-lymphoblastic leukaemia/lymphoma, NOS B-lymphoblastic leukaemia/lymphoma ...
https://en.wikipedia.org/wiki/Tumors_of_the_hematopoietic_and_lymphoid_tissues
Serous cystadenocarcinomaSerous cystadenocarcinoma
Journal of Gastrointestinal Surgery. 13 (10): 1864-1868. doi:10.1007/s11605-009-0926-3. PMC 2759006. PMID 19459016. Friebe V, ... Neoplasm stubs). ...
https://en.wikipedia.org/wiki/Serous_cystadenocarcinoma
Anal cancerAnal cancer
... is a cancer which arises from the anus, the distal opening of the gastrointestinal tract. Symptoms may include ... Chemotherapy commonly used is similar to other squamous cell epithelial neoplasms, such as platinum analogues, anthracyclines ... and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial. Int J Radiation Oncol Biol Phys, 2013, Vol. ... Gastrointestinal cancer, Papillomavirus-associated diseases, Infectious causes of cancer, Wikipedia medicine articles ready to ...
https://en.wikipedia.org/wiki/Anal_cancer
Proton therapyProton therapy
"TREATING GASTROINTESTINAL MALIGNANCY WITH PROTON THERAPY". IBA White Paper. September 2016. Tae Hyung Kim (2020). "Proton beam ... Two prominent examples are pediatric neoplasms (such as medulloblastoma) and prostate cancer. Irreversible long-term side ... Indeed, the largest study to date showed that IMRT compared with proton therapy was associated with less gastrointestinal ... gastrointestinal and bladder side effects. Proton therapy for eye tumors is a special case since this treatment requires only ...
https://en.wikipedia.org/wiki/Proton_therapy
O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine...O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine...
In this study, we examined the MGMT and GLUT2 status in gastrointestinal neuroendocrine neoplasm (NEN). We studied 84 NEN cases ... 33 foregut and 37 hindgut GI-NETs and 14 gastrointestinal neuroendocrine carcinomas (GI-NECs). In GI-NETs, MGMT scores of ≥2 ... and gastrointestinal (GI-NET) neuroendocrine tumors but its therapeutic efficacy is relatively low in GI-NETs. Therefore, it ... In this study, we examined the MGMT and GLUT2 status in gastrointestinal neuroendocrine neoplasm (NEN). We studied 84 NEN cases ...
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-07579-6
Lower Gastrointestinal Bleeding: Practice Essentials, Background, AnatomyLower Gastrointestinal Bleeding: Practice Essentials, Background, Anatomy
... of episodes of gastrointestinal (GI) hemorrhage, with an annual incidence of about 20-27 cases per 100,000 population in ... Neoplasm. Neoplastic bleeding can be from a polyp or carcinoma. Colon cancer is the predominant cause of neoplastic bleeding ... Lower gastrointestinal bleeding (LGIB) accounts for approximately 20%-33% of episodes of gastrointestinal (GI) hemorrhage, with ... Table 1. Common Causes of Lower Gastrointestinal Bleeding in Adults. *Table 2. Common Causes of Lower Gastrointestinal Bleeding ...
https://www.medscape.com/answers/188478-36709/which-infectious-agents-may-cause-lower-gastrointestinal-gi-bleeding-lgib
Pediatric Gastrointestinal Neoplasms: Background, Esophageal Neoplasms, Gastric NeoplasmsPediatric Gastrointestinal Neoplasms: Background, Esophageal Neoplasms, Gastric Neoplasms
Primary GI neoplasms in children are rare entities. In 1960, the incidence of GI malignancies arising from the bowel was ... encoded search term (Pediatric Gastrointestinal Neoplasms) and Pediatric Gastrointestinal Neoplasms What to Read Next on ... Pediatric Gastrointestinal Neoplasms Updated: May 31, 2022 * Author: Nathaniel Koo, MD; Chief Editor: Max J Coppes, MD, PhD, ... Primary gastrointestinal (GI) neoplasms in children are rare. [1] In 1960, the incidence of GI malignancies arising from the ...
https://emedicine.staging.medscape.com/article/940278-overview
Results of search for 'su:{Gastrointestinal neoplasms.}' › WHO HQ Library catalog
Results of search for su:{Gastrointestinal neoplasms.} Refine your search. *. Availability. * Limit to currently available ... Gastrointestinal cancer / edited by Jerome J. DeCosse and Paul Sherlock. 1, . by DeCosse, Jerome J , Sherlock, Paul. ... Combined modality therapy of gastrointestinal tract cancer / P. Schlag, P. Hohenberger, U. Metzger (eds.) by Schlag, Peter , ... Nutrition in gastrointestinal disease / edited by Robert C. Kurtz. by Kurtz, Robert C. ...
https://kohahq.searo.who.int/cgi-bin/koha/opac-search.pl?q=su:%7BGastrointestinal%20neoplasms.%7D
Find a Doctor in Your Area: Search Results - SharecareFind a Doctor in Your Area: Search Results - Sharecare
Gastrointestinal Neoplasms (14) * Pancreatic Neoplasms (11) * Head & Neck Neoplasms (6) * Gynecologic Neoplasms (5) ...
https://www.sharecare.com/find-a-doctor/specialty/hematology/mn-minnesota/austin
Simultaneous Triple Primary Neoplasms in the Gastrointestinal Tract: A Rare Case Report | BiomedresSimultaneous Triple Primary Neoplasms in the Gastrointestinal Tract: A Rare Case Report | Biomedres
Multiple primary neoplasms (MPNs) were not recognized until the 1890s [1]. ... Simultaneous Triple Primary Neoplasms in the Gastrointestinal Tract: A Rare Case Report Volume 14 - Issue 2 ... Keywords: Case Report; Multiple Primary Neoplasms; Primary Colon Cancer. Abbrevations: MPNs: Multiple Primary Neoplasms; CT: ... Background: Multiple primary neoplasms (MPNs) are of rare occurrence. The majority of MPNs are double primary neoplasms while ...
https://biomedres.us/fulltexts/BJSTR.MS.ID.002517.php
Gastrointestinal Complications (PDQ®) - PDQ Cancer Information Summaries - NCBI BookshelfGastrointestinal Complications (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Get detailed information about gastrointestinal complications and ways to manage them in this clinician summary. ... Gastrointestinal complications (e.g., constipation, bowel obstruction, diarrhea) can be tumor or treatment related and are ... This agent inhibits the release of several gastrointestinal hormones and reduces gastrointestinal secretions.[22,23][Level of ... Symptoms of gastrointestinal GVHD include nausea and vomiting, severe abdominal pain and cramping, and watery, green diarrhea.[ ...
https://www.ncbi.nlm.nih.gov/books/NBK65768/
Nature Reviews Clinical OncologyNature Reviews Clinical Oncology
Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies ...
https://www.nature.com/nrclinonc/?type=editorial&year=2010&error=cookies_not_supported&code=3f37c03e-beea-4326-a5a3-8c62f61aa787
Nature Reviews Clinical OncologyNature Reviews Clinical Oncology
Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies ...
https://www.nature.com/nrclinonc/?year=2018&error=cookies_not_supported&code=1d498cbb-46ef-4c9a-bf33-17983f906749
Gastrointestinal stromal tumor: MedlinePlus GeneticsGastrointestinal stromal tumor: MedlinePlus Genetics
... is a type of tumor that occurs in the gastrointestinal tract, most commonly in the stomach or small intestine. Explore symptoms ... Gastrointestinal stromal neoplasm. *Gastrointestinal stromal sarcoma. *GIST. Additional Information & Resources. Genetic ... A gastrointestinal stromal tumor (GIST) is a type of tumor that occurs in the gastrointestinal tract, most commonly in the ... Sometimes, tumors cause bleeding into the gastrointestinal tract, which may lead to low red blood cell counts (anemia. ) and, ...
https://medlineplus.gov/genetics/condition/gastrointestinal-stromal-tumor/
Systematic study of novel lncRNAs in different gastrointestinal cancer cellsSystematic study of novel lncRNAs in different gastrointestinal cancer cells
... which could be involved in important pathways related to gastrointestinal cancer development. Overall, we provide a rich ... Gastrointestinal Neoplasms / genetics* * Gene Expression Profiling * Gene Expression Regulation, Neoplastic* * Humans * RNA, ... Systematic study of novel lncRNAs in different gastrointestinal cancer cells Discov Med. 2016 Mar;21(115):159-71. ... Material and methods: To investigate the association of lncRNAs to gastrointestinal cancers, 12 cases of esophageal cancer and ...
https://pubmed.ncbi.nlm.nih.gov/27115166/
ROMAN: A Study to Investigate the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer -...ROMAN: A Study to Investigate the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer -...
Head and Neck Neoplasms. Mucositis. Stomatitis. Neoplasms by Site. Neoplasms. Gastroenteritis. Gastrointestinal Diseases. ...
https://www.clinicaltrials.gov/ct2/show/NCT03689712
A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor - Full Text View - ClinicalTrials.govA Study of Famitinib in Patients With Gastrointestinal Stromal Tumor - Full Text View - ClinicalTrials.gov
Neoplasms. Neoplasms, Connective Tissue. Neoplasms, Connective and Soft Tissue. Neoplasms by Histologic Type. Gastrointestinal ... A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor. The safety and scientific validity of this study is the ... MedlinePlus Genetics related topics: Gastrointestinal stromal tumor Genetic and Rare Diseases Information Center resources: ... A Single Arm, Open Label, Multicenter, Phase II Study of Famitinib in Patients With Gastrointestinal Stromal Tumor. ...
https://clinicaltrials.gov/ct2/show/NCT02336724
Puumala Virus Infections Associated with Cardiovascular Causes of Death - Volume 19, Number 1-January 2013 - Emerging...
... neoplasms, 34.3 ± 20.1 d (n = 3); gastrointestinal, 44 ± 39.5 d (n = 2); infections, 77.5 ± 16.3 d (n = 2); endocrine, 22 d (n ... neoplasms (C00-D48); gastrointestinal diseases (K55-K63); infectious diseases (A00-B99, excluding A94.0 and A98.5); endocrine ... Causes of death for remaining persons in the cohort were neoplasms, infectious diseases, endocrine diseases, and CNS diseases ( ...
https://wwwnc.cdc.gov/eid/article/19/1/11-1587_article
Neoplasm - WikipediaNeoplasm - Wikipedia
... or gastrointestinal duplications) due to outflow obstructions or narrowings, or abnormal connections, may also present as a ... ICD-10 classifies neoplasms into four main groups: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of ... p. Neoplasm. ISBN 978-0781733908. .. *^ "II Neoplasms". International Statistical Classification of Diseases and Related Health ... The term neoplasm is a synonym of tumor. Neoplasia denotes the process of the formation of neoplasms/tumors, and the process is ...
https://en.wikipedia.org/wiki/Neoplasia
Colorectal Cancer | Baylor MedicineColorectal Cancer | Baylor Medicine
Gastrointestinal Stromal (GIST) Tumors. *Presacral Tumors/Lesions. *Appendiceal Neoplasms. *Small Intestinal Adenocarcinoma ...
https://www.bcm.edu/healthcare/specialties/oncology/cancer-types/gastrointestinal-cancers/colorectal-cancer
Dr. Dilendra Weerasinghe, MD | Bariatric Surgery in Trinity, FL | Healthline FindCareDr. Dilendra Weerasinghe, MD | Bariatric Surgery in Trinity, FL | Healthline FindCare
Neoplasm of Gastrointestinal Tract ... View other providers who treat Neoplasm of Gastrointestinal ...
https://www.healthline.com/find-care/provider/dr-dilendra-weerasinghe-1710207352
NIOSHTIC-2 Search Results - Full View
Dr. Faiz Shakir, MD - Gastroenterology Specialist in Sandy, UT | HealthgradesDr. Faiz Shakir, MD - Gastroenterology Specialist in Sandy, UT | Healthgrades
Neoplasm of Gastrointestinal Tract. *Non-Alcoholic Fatty Liver Disease. *Noninfectious Gastroenteritis and Colitis ...
https://www.healthgrades.com/physician/dr-faiz-shakir-x2wbm
Pathology for the Physical Therapist Assistant - 9780323395496Pathology for the Physical Therapist Assistant - 9780323395496
4. The Gastrointestinal System 5. The Renal and Urologic Systems. 6. Central Nervous System Neoplasms 7. Epilepsy. 8. Headache ... Musculoskeletal Neoplasms. 17. Bone, Joint, and Soft Tissue Diseases and Disorders Section 4: Pathology of the Nervous System. ... Twelve e-chapters offer supplemental information in the areas of behavioral issues, the gastrointestinal system, vestibular ...
https://www.us.elsevierhealth.com/pathology-for-the-physical-therapist-assistant-9780323395496.html
Gastric tissue biopsy and cultureGastric tissue biopsy and culture
Epithelial neoplasms of the stomach. In: Iacobuzio-Donahue CA, Montgomery E, eds. Gastrointestinal and Liver Pathology. 2nd ed ... Sleisenger and Fordtrans Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 10th ed. Philadelphia, PA: ... Sleisenger and Fordtrans Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 10th ed. Philadelphia, PA: ...
https://www.ucsfhealth.org/medical-tests/gastric-tissue-biopsy-and-culture
Find a Doctor in Your Area: Search Results - SharecareFind a Doctor in Your Area: Search Results - Sharecare
Gastrointestinal Neoplasms (11) * Head & Neck Neoplasms (10) * Pancreatic Neoplasms (10) * Skeletal System Neoplasms (8) ...
https://www.sharecare.com/find-a-doctor/specialty/oncology/fl-florida/crestview
Gastric Neoplasms: A Multidisciplinary Approach via the SAGES Surgical CalendarGastric Neoplasms: A Multidisciplinary Approach via the SAGES Surgical Calendar
Society of American Gastrointestinal and Endoscopic Surgeons. 11300 W. Olympic Blvd Suite 600. Los Angeles, CA 90064 USA. [ ... This educational symposium will update the medical community on the state-of-the-art care of gastric neoplasms while focusing ...
https://www.sages.org/meetings/calendar/event/gastric-neoplasms-a-multidisciplinary-approach/
Breast Cancer Screening: Group Education | The Community GuideBreast Cancer Screening: Group Education | The Community Guide
... splenic neoplasms/ or exp *thoracic neoplasms/. *** Bold terms replace "exp *gastrointestinal neoplasms/" ... cecal neoplasms/ or exp *duodenal neoplasms/ or exp *ileal neoplasms/ or exp *jejunal neoplasms/ or exp *stomach neoplasms/ or ... cecal neoplasms/ or exp *duodenal neoplasms/ or exp *ileal neoplasms/ or exp *jejunal neoplasms/ or exp *stomach neoplasms/ or ... pc or exp COLONIC NEOPLASMS/pc or exp SIGMOID NEOPLASMS/pc or exp RECTAL NEOPLASMS/pc or exp ANUS NEOPLASMS/pc or exp NEOPLASMS ...
https://thecommunityguide.org/findings/cancer-screening-group-education-clients-breast-cancer.html
Familial Adenomatous Polyposis Treatment & Management: Medical Care, Surgical Care, ConsultationsFamilial Adenomatous Polyposis Treatment & Management: Medical Care, Surgical Care, Consultations
Malignant neoplasms of the large intestine. Feldman M, Friedman LS, Brandt LJ, eds. In: Sleisenger & Fordtrans ... ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. ... Division of Gastrointestinal Endoscopy, Atlanta Veterans Affairs Medical Center. Kamil Obideen, MD is a member of the following ... American Society for Gastrointestinal Endoscopy. Disclosure: Nothing to disclose. ...
https://emedicine.medscape.com/article/175377-treatment
Publications | Benny GeigersPublications | Benny Geiger's
LEVY, R; CZERNOBILSKY, B; GEIGER, B (1988). STUDY OF CYTOKERATINS IN GASTROINTESTINAL-TRACT AND ITS NEOPLASMS. Journal Of ... Levy, R; Czernobilsky, B; Geiger, B (1992). Cytokeratin polypeptide in gastrointestinal adenocarcinomas displaying squamous ... COEXPRESSION OF NEURO-ENDOCRINE MARKERS AND EPITHELIAL CYTOSKELETAL PROTEINS IN BRONCHOPULMONARY NEURO-ENDOCRINE NEOPLASMS. ...
https://www.weizmann.ac.il/immunology/Geiger/publications?qt-view__publications__page=0
Advanced Search Results - Public Health Image Library(PHIL)Advanced Search Results - Public Health Image Library(PHIL)
Categories: Gastrointestinal Neoplasms Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
https://phil.cdc.gov/AdvancedSearchResults.aspx?Search=Gastrointestinal+Neoplasms&parentid=11366&catid=11371
Gengraf Oral Solution (Cyclosporine Oral Solution): Uses, Dosage, Side Effects, Interactions, WarningGengraf Oral Solution (Cyclosporine Oral Solution): Uses, Dosage, Side Effects, Interactions, Warning
Neoplasms: skin malignancies [squamous cell (0.9%) and basal cell (0.4%) carcinomas]. Reticuloendothelial: platelet, bleeding, ... Gastrointestinal: constipation, dysphagia, enanthema, eructation, esophagitis, gastric ulcer, gastritis, gastroenteritis, ... Neoplasms: breast fibroadenosis, carcinoma. Psychiatric: anxiety, confusion, decreased libido, emotional lability, impaired ... The most common forms of neoplasms are non-Hodgkins lymphoma and carcinomas of the skin. The risk of malignancies in ...
https://www.rxlist.com/gengraf-oral-solution-drug.htm
TractTumorsPancreatic NeoplasmsCancersStromal tumorMalignantCancerComputed TomographyGastroesophageal RefluxAmerican Society fGISTPancreasBenign NeoplasmMucinous neoplasmLymphomaUpper gastrointNeuroendocrinePrimaryCarcinomaStomachComplicationsDisordersEpithelialClinicalDisorderIncidenceEndoscopicSynonym
Tract12
  • The gastrointestinal (GI) tract is one of the most frequent primary sites of NETs, and 12-22% of patients with NETs harbor metastatic lesions at the time of initial clinical diagnosis [ 1 ]. (biomedcentral.com)
  • Consequently, this article focuses on the more common benign and malignant neoplasms of the GI tract in children, in addition to information gleaned from the relatively sparse literature. (medscape.com)
  • Combined modality therapy of gastrointestinal tract cancer / P. Schlag, P. Hohenberger, U. Metzger (eds. (who.int)
  • Gastrointestinal disorder (functional problems of gastrointestinal tract) is found to be associated with 2,263 drugs and 1,807 conditions by eHealthMe. (ehealthme.com)
  • Esophageal cancer is one of the leading causes of mortality among the neoplasms that affect the gastrointestinal tract. (scielo.br)
  • Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL . (bvsalud.org)
  • All but one failure in the EGD group was secondary to a lack of a bulge seen in the gastrointestinal (GI) tract. (micrornaarray.com)
  • NETs are a group of tumors with heterogenous malignancy that evolve from neuroendocrine cells, with the lung being the second target organ after the gastrointestinal tract. (spandidos-publications.com)
  • In addition to the single pulmonary localizations there have been cases described of two or more carcinoid tumors or tumorlets of the lung, gastrointestinal tract and pancreas. (spandidos-publications.com)
  • Ampullary cancer accounts for approximately 0.5% of all gastrointestinal tract malignancies. (medscape.com)
  • The multicomponent peptide complex LowacidTIDE PLUS forte is a natural and safe product for normalizing functions of the mucous membranes of the gastrointestinal tract in chronic gastritis with low acidity. (personalizedotc.com)
  • Peptides normalize functions of the gastrointestinal tract in chronic gastritis with low acidity and restore, heal cells of gastric tissues. (personalizedotc.com)
Tumors11
  • Streptozocin (STZ) is used for treating both pancreatic (PanNET) and gastrointestinal (GI-NET) neuroendocrine tumors but its therapeutic efficacy is relatively low in GI-NETs. (biomedcentral.com)
  • What Are Gastrointestinal Stromal Tumors? (medlineplus.gov)
  • How Are Gastrointestinal Stromal Tumors Diagnosed? (medlineplus.gov)
  • How Are Gastrointestinal Stromal Tumors Staged? (medlineplus.gov)
  • What Are the Risk Factors for Gastrointestinal Stromal Tumors? (medlineplus.gov)
  • Do We Know What Causes Gastrointestinal Stromal Tumors? (medlineplus.gov)
  • For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. (icd10data.com)
  • Gastrointestinal stromal tumors (GIST) are a heterogeneous group of neoplasms whose biologic behavior is difficult to predict. (cun.es)
  • Recent studies show favorable diagnosis efficiency in a variety of tumors, especially in gastrointestinal cancer, but the previous studies were all small-sample data or case reports. (centerwatch.com)
  • Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms most frequently found in the stomach and presenting without symptoms or with unspecific ones such as hemorrhage and abdominal pain. (irb.hr)
  • [ 1 ] Prior to the recently reported increase, the quoted incidence for ampullary carcinoma was 0.2% of all gastrointestinal malignancies and 6% of all periampullary tumors. (medscape.com)
Pancreatic Neoplasms3
  • A gastrointestinal pathologist, she runs a research laboratory dedicated to the evolutionary biology and genetics of pancreatic neoplasms. (agora-gallery.com)
  • EUS has an integral role in the diagnosis of pancreatic cancer given its high sensitivity for detecting pancreatic neoplasms and the access it affords to perform fine needle aspiration (FNA) of the suspected lesions. (abdominalkey.com)
  • Carcinoma of the ampulla of Vater tends to manifest early due to biliary outflow obstruction, as opposed to pancreatic neoplasms that often are advanced at the time of diagnosis. (medscape.com)
Cancers4
  • To investigate the association of lncRNAs to gastrointestinal cancers, 12 cases of esophageal cancer and hepatic cancer, 16 cases of gastric cancer and colorectal cancer and their matched adjacent tissue samples, 12 esophageal cancer cell lines, 7 gastric cancer cell lines, 10 colorectal cancer cell lines, and 11 hepatic cancer cell lines were examined. (nih.gov)
  • [7] Malignant neoplasms are also simply known as cancers and are the focus of oncology . (wikipedia.org)
  • Smad4, a tumor suppressor, is often mutated in human gastrointestinal cancers. (elsevier.com)
  • The alteration of ELF and/or Smad4 expression and function in the TGF-beta signaling pathway may be induced by enhancement of ELF degradation, which is mediated by the high level expression of PRAJA in gastrointestinal cancers. (elsevier.com)
Stromal tumor3
  • What Happens After Treatment for Gastrointestinal Stromal Tumor? (medlineplus.gov)
  • The purpose of this study is to evaluate the efficacy and safety profile of Famitinib in patients with advanced or metastatic gastrointestinal stromal tumor who failed from imatinib therapy. (clinicaltrials.gov)
  • Unresectable advanced or metastatic, histologically-confirmed, gastrointestinal stromal tumor.Patients has been failed from last imatinib treatment due to disease progression or unacceptable toxicity and unable to use sunitinib. (clinicaltrials.gov)
Malignant14
  • benign neoplasms , in situ neoplasms , malignant neoplasms , and neoplasms of uncertain or unknown behavior. (wikipedia.org)
  • A neoplasm can be benign , potentially malignant, or malignant ( cancer ). (wikipedia.org)
  • Potentially-malignant neoplasms include carcinoma in situ . (wikipedia.org)
  • Malignant neoplasms are commonly called cancer. (wikipedia.org)
  • C48.1 Malignant neoplasm of specified parts of peri. (icd10data.com)
  • C48.2 Malignant neoplasm of peritoneum, unspecified. (icd10data.com)
  • C48.8 Malignant neoplasm of overlapping sites of re. (icd10data.com)
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. (icd10data.com)
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified ( C25.9 ). (icd10data.com)
  • FAP can be detected in various of malignant neoplasms and is associated to tumor cell migration, invasion, and angiogenesis. (centerwatch.com)
  • Epithelioid angiosarcoma is a rare malignant neoplasm found in vascular endothelial cells. (bvsalud.org)
  • Angiosarcoma is a rare malignant vascular neoplasm which constitutes less than 1% of all sarcomas. (bvsalud.org)
  • Epithelioid angiosarcoma (EA) is a rare variant of angiosarcoma, which is characterized by a high-grade malignant neoplasm, which consists of an atypical, multilayered, or solid endothelial proliferation and vasoformative architecture, presenting necrosis and an area of hemorrhage 1-5 . (bvsalud.org)
  • BACKGROUND: Worldwide, colorectal cancer (CRC) is a malignant neoplasm that affects both genders. (unifesp.br)
Cancer13
  • Gastrointestinal cancer / edited by Jerome J. DeCosse and Paul Sherlock. (who.int)
  • This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the pathophysiology and treatment of gastrointestinal complications, including constipation, impaction, bowel obstruction, diarrhea, and radiation enteritis. (nih.gov)
  • Gastrointestinal complications such as constipation, impaction, bowel obstruction, diarrhea, and radiation enteritis are common problems for patients with cancer. (nih.gov)
  • In addition, we analyzed the differentially expressed lncRNAs in gastrointestinal cancer cells before and after treatment with 5-Aza. (nih.gov)
  • Based on RNA-Seq and bioinformatics analysis, we have identified a significant number of novel lncRNAs, which could be involved in important pathways related to gastrointestinal cancer development. (nih.gov)
  • Overall, we provide a rich resource for identifying new biomarkers and studying novel lncRNA regulation pathways in gastrointestinal cancer. (nih.gov)
  • Secondary neoplasm refers to any of a class of cancerous tumor that is either a metastatic offshoot of a primary tumor, or an apparently unrelated tumor that increases in frequency following certain cancer treatments such as chemotherapy or radiotherapy . (wikipedia.org)
  • Rarely there can be a metastatic neoplasm with no known site of the primary cancer and this is classed as a cancer of unknown primary origin . (wikipedia.org)
  • Inactivation of the TGF-beta pathway often occurs in malignancies of the gastrointestinal system, including gastric cancer. (elsevier.com)
  • Conversely, biannual endoscopy is recommended in the Manual of Gastric Cancer Screening published by the Japanese Society of Gastrointestinal Cancer Screening ( 7,8 ). (lww.com)
  • Not taking the opportunity to obtain gastric biopsy samples for Helicobacter pylori testing during upper gastrointestinal endoscopy is a mistake in patients with dyspepsia or in the setting of a family history of gastric cancer. (ueg.eu)
  • Glutathione S-transferases genes variants and chemotherapy efficacy in gastrointestinal cancer patients: a meta-analysis based on 50 pharmacogenetic studies. (cdc.gov)
  • The 5-year survival rate for pancreatic cancer is 5%, which is the lowest among gastrointestinal malignancies. (abdominalkey.com)
Computed Tomography1
  • We report the case of a male patient with obscure overt gastrointestinal bleed in whom repeated upper gastrointestinal endoscopy, colonoscopy, computed tomography scanning and exploratory laparotomy showed no specific pathology. (who.int)
Gastroesophageal Reflux1
  • Gastrointestinal problems including gastroesophageal reflux disease, constipation, and. (bvsalud.org)
American Society f1
  • During the investigation of chronic diarrhoea, for instance, sampling normal-appearing colonic mucosa is the only method available for diagnosing microscopic colitis and is one of the quality indicators in colonoscopy according to the American Society for Gastrointestinal Endoscopy (ASGE). (ueg.eu)
GIST1
  • This educational symposium will update the medical community on the state-of-the-art care of gastric neoplasms while focusing on the importance of a multidisciplinary approach to the diagnosis and treatment of these rare and complicated disease entities including GIST and gastric adenocarcinoma. (sages.org)
Pancreas2
  • Intraductal papillary mucinous neoplasm of pancreas, high grade. (webpathology.com)
  • Duodenal diverticula mimicking cystic neoplasm of the pancreas: CT and MR imaging findings in seven patients. (clinicalimaging.org)
Benign Neoplasm1
  • A musculoskeletal system benign neoplasm that is located_in connective tissue. (mcw.edu)
Mucinous neoplasm3
  • Management of low-grade appendiceal mucinous neoplasm (LAMN) is controversial, and we discuss the importance of the case. (hindawi.com)
  • The case of young male post stump appendectomy with histopathology showing LAMN in the stump of the appendix, which to our knowledge, is the first in the medical literature and, discuss the stump appendicitis and incomplete appendectomy concerning malignancy, mucinous neoplasm, and adenocarcinoma. (hindawi.com)
  • At the same time, the histopathology of the stump showed appendix measuring 4 cm in length and 0.6 cm in diameter with low-grade appendiceal mucinous neoplasm (LAMN) (Figures 5 - 7 ). (hindawi.com)
Lymphoma2
  • For lymphoid neoplasms, e.g. lymphoma and leukemia , clonality is proven by the amplification of a single rearrangement of their immunoglobulin gene (for B cell lesions) or T cell receptor gene (for T cell lesions). (wikipedia.org)
  • Increased susceptibility to infection and the possible development of lymphoma and other neoplasms may result from the increase in the degree of immunosuppression in transplant patients. (rxlist.com)
Upper gastroint3
  • Upper gastrointestinal endoscopy detected esophageal and duodenal varices. (go.jp)
  • Upper gastrointestinal endoscopy detected a submucosal lesion and computerized tomography revealed a node near the liver. (irb.hr)
  • 6 When there is a clinical and/or serological suspicion of coeliac disease, biopsy samples should be obtained during upper gastrointestinal endoscopy, both from the bulb and distal duodenum, while the patient is on a gluten-containing diet. (ueg.eu)
Neuroendocrine5
  • In this study, we examined the MGMT and GLUT2 status in gastrointestinal neuroendocrine neoplasm (NEN). (biomedcentral.com)
  • We studied 84 NEN cases: 33 foregut and 37 hindgut GI-NETs and 14 gastrointestinal neuroendocrine carcinomas (GI-NECs). (biomedcentral.com)
  • Abdel-Rahman O , Ghosh S , Morrish D . Impact of baseline body mass index on the outcomes of patients with neuroendocrine neoplasms. (wjgnet.com)
  • Lan X , Fazio N, Abdel-rahman O. Exploring the Relationship between Obesity, Metabolic Syndrome and Neuroendocrine Neoplasms. (wjgnet.com)
  • Budek M , Nuszkiewicz J , Piórkowska A , Czuczejko J , Szewczyk-Golec K . Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms. (wjgnet.com)
Primary9
  • Primary gastrointestinal (GI) neoplasms in children are rare. (medscape.com)
  • Multiple primary neoplasms (MPNs) are of rare occurrence. (biomedres.us)
  • The majority of MPNs are double primary neoplasms while triple and quadruple primary neoplasms are extremely rare. (biomedres.us)
  • Here, we report a rare case of a 78-year-old woman diagnosed with simultaneous triple primary neoplasms in the ascending colon, the transverse colon and the appendix. (biomedres.us)
  • Simultaneous triple primary neoplasms are uncommon cases. (biomedres.us)
  • Surgery-based comprehensive therapy is the recommended therapy for simultaneous multiple primary neoplasms. (biomedres.us)
  • Multiple primary neoplasms (MPNs) were not recognized until the 1890s [1]. (biomedres.us)
  • The majority of MPNs are metachronous double primary neoplasms, while simultaneous triple and quadruple primary neoplasms are much rarer [6]. (biomedres.us)
  • clonality studies suggest that most of these neoplasms are separate primary lesions. (cancer.gov)
Carcinoma1
  • [12] [13] Some neoplasms do not form a tumor - these include leukemia and most forms of carcinoma in situ . (wikipedia.org)
Stomach1
Complications1
  • Bhattacharya S, Pavletic S, Heller T. Gastrointestinal complications of hematopoietic cell transplant in: Savani BN, ed. (nih.gov)
Disorders1
  • Various neuromuscular, reproductive, gastrointestinal, and urologic disorders may cause or contribute to chronic pain. (medicineshoppe.com)
Epithelial1
  • CAFs are the predominant component in the stroma of epithelial neoplasms. (centerwatch.com)
Clinical1
  • The phase IV clinical study analyzes which people take Effexor xr and have Gastrointestinal disorder. (ehealthme.com)
Disorder4
  • Gastrointestinal disorder is found among people who take Effexor xr, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months. (ehealthme.com)
  • Among them, 140 people (0.46%) have Gastrointestinal disorder. (ehealthme.com)
  • What is Gastrointestinal disorder? (ehealthme.com)
  • Do you take Effexor xr and have Gastrointestinal disorder? (ehealthme.com)
Incidence1
  • Interestingly, the incidence of pancreatic endocrine neoplasms increased over the same time periods by 106% in men and 125% in women. (abdominalkey.com)
Endoscopic1
  • 1 , 2 Current guidelines do not recommend antithrombotic discontinuation for low-risk endoscopic procedures, 3 , 4 with European Society of Gastrointestinal Endoscopy (ESGE) guidelines suggesting an international normalized ratio (INR) check and warfarin dose adjustment one week prior to the procedure. (ueg.eu)
Synonym1
  • In modern English, tumor is used as a synonym for neoplasm (a solid or fluid-filled cystic lesion that may or may not be formed by an abnormal growth of neoplastic cells) that appears enlarged in size. (wikipedia.org)
CML Following Treatment for Primary Neoplasms
CML Following Treatment for Primary Neoplasms (medscape.com)
Gastrointestinal stromal tumor: MedlinePlus Genetics
Gastrointestinal stromal tumor: MedlinePlus Genetics (medlineplus.gov)
Lower Gastrointestinal Bleeding: Practice Essentials, Background, Anatomy
Lower Gastrointestinal Bleeding: Practice Essentials, Background, Anatomy (medscape.com)
Surgery for pancreatic cancer: MedlinePlus Medical Encyclopedia
Surgery for pancreatic cancer: MedlinePlus Medical Encyclopedia (medlineplus.gov)
Gastrointestinal Complications (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Gastrointestinal Complications (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf (ncbi.nlm.nih.gov)
A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor - Full Text View - ClinicalTrials.gov
A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor - Full Text View - ClinicalTrials.gov (clinicaltrials.gov)
Neoplasm - Wikipedia
Neoplasm - Wikipedia (en.wikipedia.org)
Gastric tissue biopsy and culture
Gastric tissue biopsy and culture (ucsfhealth.org)
Publications | Benny Geiger's
Publications | Benny Geiger's (weizmann.ac.il)
Familial Adenomatous Polyposis Treatment & Management: Medical Care, Surgical Care, Consultations
Familial Adenomatous Polyposis Treatment & Management: Medical Care, Surgical Care, Consultations (emedicine.medscape.com)
Pathology of Testicular Choriocarcinoma: Overview, Etiology and Location, Clinical Features
Pathology of Testicular Choriocarcinoma: Overview, Etiology and Location, Clinical Features (emedicine.medscape.com)
Gengraf Oral Solution (Cyclosporine Oral Solution): Uses, Dosage, Side Effects, Interactions, Warning
Gengraf Oral Solution (Cyclosporine Oral Solution): Uses, Dosage, Side Effects, Interactions, Warning (rxlist.com)
Epistaxis: Practice Essentials, Anatomy, Pathophysiology
Epistaxis: Practice Essentials, Anatomy, Pathophysiology (medscape.com)
Traditional serrated adenoma (TSA): morphological questions, queries and quandaries | Journal of Clinical Pathology
Traditional serrated adenoma (TSA): morphological questions, queries and quandaries | Journal of Clinical Pathology (jcp.bmj.com)
Webpathology.com: A Collection of Surgical Pathology Images
Webpathology.com: A Collection of Surgical Pathology Images (webpathology.com)
Pathology for the Physical Therapist Assistant - Elsevier eBook on VitalSource, 2nd Edition - 9780323395472
Pathology for the Physical Therapist Assistant - Elsevier eBook on VitalSource, 2nd Edition - 9780323395472 (evolve.elsevier.com)
(emedicine.medscape.com)
(emedicine.medscape.com)
DailyMed - CYCLOSPORINE solution
DailyMed - CYCLOSPORINE solution (dailymed.nlm.nih.gov)
CycloSPORINE Oral Solution USP MODIFIED
CycloSPORINE Oral Solution USP MODIFIED (dailymed.nlm.nih.gov)
Dermatologic Manifestations of Gastrointestinal Disease: Overview, Dermatology and the Pharynx, Dermatology and the Esophagus
Dermatologic Manifestations of Gastrointestinal Disease: Overview, Dermatology and the Pharynx, Dermatology and the Esophagus (emedicine.medscape.com)